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Abstract
Background: State-of-the-art radiotherapy medical records include reliable estimates of the
therapeutic radiation but are known to underestimate the stray radiation exposures by 40% away
from the treatment field. Most commonly, stray radiation exposures are reconstructed using
empirical formulas and/or lookup tables containing machine-specific dose measurements. The
purpose of this study was to develop a physics-based model to calculate exposures to the whole
body of patients who receive external beam photon radiotherapy.
Methods: We developed a physics-based analytic algorithm to predict absorbed dose from
therapeutic, scatter, and leakage radiation. The model includes separate terms to characterize
photon production, attenuation, and scattering in the treatment unit as well as attenuation and
scatter of radiation within the phantom. It was developed using measurements of total absorbed
dose in a water-box phantom from a 6 MV medical linear accelerator and was validated against
measured profiles in water using several clinically representative treatment fields.
Results: Our dose algorithm reproduces the measured dose profiles in water from 1.5 to 10 cm
in depth and 35 cm off-axis distance. At least 90% of predicted doses agreed within 10% or 3
mm of measured absorbed doses for positions where those doses were greater than 5% of
therapeutic dose, and within 2 mGy of stray dose per Gy of therapeutic dose or 10 mm of
measured doses at other locations. Computation times for 10 million dose points within a
phantom were less than 6.5 minutes.
Conclusions: The results suggest that it is feasible to use a physics-based model to accurately
and quickly predict whole body exposures from radiation therapy. A potentially important
advantage of a physics-based approach, such as the algorithm proposed in this work, is that the

viii

model is inherently more readily adaptable to a wide variety of treatment units and treatment
techniques than models based on empirical formulae or machine specific lookup-tables.

ix

Chapter 1 Introduction and Background
1.1 General
Cancer is one of the most significant health care problems in America today. It is
estimated that 1 in 2 men and women will be diagnosed with some form of cancer in their
lifetime (Howlader, et al., 2009). Nearly two thirds of cancer patients will receive radiation
therapy at some point in their care (Smart, 2010) and the vast majority of these radiotherapy
treatments will be done with photon therapy (DeVita, Jr, Lawrence, & Rosenberg, 2008). Thus,
it is expected that a very large portion of the general population will be treated with photon
radiotherapy.
Most external beam photon therapy treatments today are delivered by electron linear
accelerators, or linacs. Linacs impinge an electron beam upon a stopping length, high Z target,
normally made of tungsten. The slowing of electrons in the target results in Bremsstrahlung
photon radiation. This photon beam is then passed through a series of beam modifying devices
in the treatment head to shape the beam to the desired size and intensity profile for treatment
(Khan, 2010). Figure 1 is a diagram depicting the main beam shaping and modifying components
in a typical linac head.
Therapeutic radiation is that which passes through all collimating apertures and typically
delivers a large dose to a small volume within the patient. Smaller levels of unwanted stray
radiation, however, are also incident upon the whole body. There are three main sources of stray
radiation: photon leakage through the treatment head, photon scatter from the collimation
system, and photon scatter within the patient. Additionally, photoneutrons are generated, mainly
in the treatment head, at electron energies greater than approximately 8 MeV (Awotwi-Pratt &
Spyrou, 2007; NCRP, 2005). Figure 2 is a schematic diagram showing a patient and treatment
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Figure 1.1 – Typical components in a medical linear accelerator head. Diagram of the
components of a typical linac head for creating therapeutic photon beams (Mesbahi, Fix,
Allahverdi, Grein, & Garaati, 2005).
head with the primary radiation represented in red and the blue haze depicting the bath of stray
radiation to which the patient is unintentionally exposed. The dose deposited by this stray
radiation can cause numerous late effects, including second malignancy. When one considers
that second cancers account for approximately 15% of all cancers (Kosary, Ries, & Miller, 1995)
and that it is projected that by the year 2020, there will be almost 20 million cancer survivors in
the United States (de Moor, et al., 2013), a very urgent and vital need to take these out-of-field
doses into account emerges.

Figure 1.2 – Therapeutic and stray radiation exposures. Schematic diagram representing a linac
head and patient being treated. The therapeutic radiation beam is shown in red while the blue
represents the stray radiation incident upon the patient’s whole body (Newhauser & Durante,
2011).
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1.2 Statement of the Problem
While a lengthy and rich history of analytical dose model development exists in the
literature, the majority of these studies have been devoted to developing algorithms to accurately
predict the absorbed dose deposited inside of the treatment field (Johns & Cunningham, 1953;
Mackie , Scrimger, & Battista, 1985; Mohan, Chi, & Lidofsky, 1986; Ahnesjo, 1989; Han,
Mikell, Salehpour, & Mourtada, 2011). Despite the previously described importance of out-offield dose consideration, comparatively fewer works have been devoted to the analytical
modeling of total absorbed dose in this region (NCRP, 2009). As a result, to our knowledge, no
contemporary commercial treatment planning system (TPS) includes the capability to accurately
predict stray dose far from the treatment field. For example, three TPSs were recently found to
be deficient in this region. Howell et al. (2010) found that a widely-used commercial treatment
planning system (Eclipse, Varian Medical Systems, Inc., Palo Alto, CA) underestimated the outof-field doses by an average of 40%. Additionally, the magnitude by which absorbed dose was
underestimated increased with increasing distance from the treatment field. In a separate study,
Joosten et al. (2013) compared TPS predicted doses (CMS XiO, Elekta, England) to doses
calculated using Monte Carlo methods (BEAMnrc) for three different modalities of radiation
therapy for breast cancer. This study found absorbed dose differences of up to 70% in out-offield organs, even in the near-field region. We found qualitatively similar results when
comparing measured doses to TPS predicted profiles (Pinnacle, Philips Healthcare, Andover,
MA). Figure 1.3 shows a measured absorbed dose profile along with the corresponding TPS
calculated doses. In this figure it can be seen that the TPS underestimated the absorbed dose
outside of the 1% isodose line. Beyond a distance of 18 cm from the central axis (CAX), an
absorbed dose of 0 mGy per Gy therapeutic dose was predicted by the TPS while the measured
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absorbed dose over this region ranged from 5 mGy/Gy to 1 mGy/Gy. Thus, there is a systematic
underestimation of stray radiation exposures by commonly used clinical treatment planning
systems.
1000
Treatment Planning System
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Figure 1.3 – Comparison of measured and TPS calculated dose profiles. Plot of dose profiles
for a 10 x 10 cm2 treatment field in the in-plane direction at a depth of 1.5 cm. Doses were
predicted using a commercial TPS (Pinnacle, Philips Healthcare, Andover, MA).
1.3 Hypothesis and Specific Aims
In order to quickly and more accurately reconstruct radiation exposures from 6 MV
photon conventional radiotherapy (CRT), we proposed a simple analytical model to calculate the
absorbed dose both inside and outside of the treatment field. The hypothesis of this study is that
the absorbed dose to a homogeneous water phantom from primary, leakage, and scattered
radiation, from 6 MV CRT, can be accurately predicted with a physics-based analytical model
(within 10% dose or 3 mm distance agreement with measured dose distributions inside of the 5%
isodose line, and within 2 mGy/Gy or 10 mm agreement with measured dose distributions
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outside of the 5% isodose line) for a clinically relevant interval of locations in a water-box
phantom.
To test the hypothesis, we performed the following three specific aims:
Specific Aim 1: Develop and train the analytic absorbed dose model to 10% or better agreement
with measured doses for square photon fields in a water-box phantom.
Specific Aim 2: Validate the analytic absorbed dose model agreement to 10% or 3 mm inside of
5%, and 2 mGy/Gy or 10 mm outside of 5% with measured absorbed doses for test cases in a
water-box phantom.
Specific Aim 3: Perform uncertainty analysis, including propagation of errors to independently
assess the accuracy of the absorbed dose model.

5

Chapter 2 Methods and Materials
This chapter presents the methods and materials used in this study. The first section
overviews of the steps involved in developing the model, starting with the modeling approach
(2.1.1). Next it presents formalisms for modeling the un-collimated (2.1.2) and collimated
(2.1.3) photon fluences. It then describes the calculation of absorbed dose resulting from the
collimated fluence in air (2.1.4) and in water (2.1.5). This is followed by the model for the unattenuated leakage photon fluence (2.1.6) and descriptions of the absorbed dose model from
leakage photons in air (2.1.7) and water (2.1.8). The virtual-source model of scattered radiation
(2.1.9) is then presented along with the resulting dose in air (2.1.10) and water (2.1.11) from
head-scattered photons, and that in water (2.1.12) from phantom-scattered photons. Section 2.1
also describes the data used to develop the model (2.1.13) and how empirical adjustment
parameters were selected (2.1.14). Section 2.2 describes the methods of validation of the
absorbed dose model against absorbed dose measurements. Finally, Section 2.3 presents
methods of uncertainty analysis of the model.
2.1 Model Development
2.1.1 Analytical Model of Absorbed Dose
According to the proposed model, the total absorbed dose, DT, to a point in a water
phantom was represented as the sum of three separate components,
 =  +  +  ,

2.1

where DP, DL, and DS denoted the absorbed doses deposited by primary, leakage, and scattered
photons, respectively.
The DP and DL components of the model depend on the model of photon fluence. The
relationship between photon fluence and absorbed dose is,
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 =  ×  × 



,
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2.2

where DCPE is the absorbed dose under conditions of charged particle equilibrium (CPE), Kc is
the kinetic energy released in a medium (KERMA) due to collisional energy losses of secondary
electrons,  is the fluence of photons, E denotes the photon energy,  is the average photon

energy of the beam, 




 ,

is the mean mass energy absorption coefficient, and Z is the atomic

number of the medium in which the dose is being deposited (Attix, 1986).
Charged particle equilibrium exists for depths deeper than dmax, except where material
interfaces are present. We used measurements of total absorbed dose in a homogenous water
phantom at depths equal to or deeper than dmax to develop the model in water. Measurements in
air utilized a buildup cap of radius equal to dmax. Therefore, conditions of charged particle
equilibrium were met in all cases studied here.
Because linac photon beams are polyenergetic, the average photon beam energy is given
by,
 =

!" × #
,
!  

2.3

where  is the photon spectral fluence or the distribution of photons in energy and the terms 
and  are as previously defined. For simplicity, we assumed a roughly triangular shape for the

primary photon spectral fluence and an average photon energy equal to one-third of the peak

energy (Attix, 1986). Thus, for the 6 MV photon beams studied in this paper, the average energy
was estimated at 2 MeV.
Finally, values for the mean photon mass energy absorption coefficient were taken from
the NIST database (Hubbell & Seltzer, 2011). Specifically,
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and,


 
= 2.35 × 100$ cm$ /g
 $ %&,'()

2.4


 
= 2.61 × 100$ cm$ /g
 $ %&,5'6)

2.5

Both of these values were needed because model components for predicting DP, and DL were
first developed in air then in water. DS, was developed in two separate parts. The first
corresponded to dose deposited by photons scattered in the treatment head, DHS, which was
developed first in air then in water, while the second part represented dose deposited by photons
scattered in the phantom, DPS, which was developed only in water.
2.1.2 Un-collimated Primary Photon Fluence

The un-collimated primary photon fluence, , is related to S, the number of photons

emitted from the photon target in the treatment head. This includes photons that deposit

absorbed dose from primary and leakage radiation, but not scatter radiation, which is modeled as
originating elsewhere in the treatment head and phantom. In general, the total number of
photons produced in the target, S, is proportional to the charge of electrons incident on the target,
Q,

8 = 9×: ,

where the constant of proportionality, 9, is given by,
9=

;"<= # × <= 1
× 0 ,
>


2.6

2.7

in which the radiation yield, Y(T0), is defined to be the fraction of electron kinetic energy emitted
as electromagnetic radiation (Attix, 1986), T0 is the nominal electron beam energy, > 0 is the

elementary charge, and  is as was defined in Equation 2.2.
8

While Equation 2.6 describes the number of photons created in the target, it does not
describe the spatial distribution of photons. The effective photon source, though very small, is a
spatially distributed source (Svensson & Brahme, 1996). In this work, the finite lateral source
size was modeled with a Gaussian function,

8"?# = 8 × @"?, ?̅ , B#,

2.8

1

2.9

where ?̅ and B are the mean and standard deviation of that Gaussian, respectively, for the
Gaussian

@"?, ?̅ , B# =
where

√2DB

>

"E0E̅ #F

0
$GF ,

H

 @"?, ?̅ , B# ? = 1 .

2.10

0H

In addition to being spatially distributed, the resulting photon beam is known to produce
horns at depths shallower than 10 cm in water due to the effects of the flattening filter (Khan,
2010). In order to model these horns, the un-collimated primary photon fluence was treated as a

composite of three Gaussians. One Gaussian, @I , was located on the central axis (CAX) and the
other two, denoted by @$ and @J , were identical to one another but located symmetrically on

either side of the CAX,

8"?# = 8I × @I "?, ?̅I , BI # + 8$ × @$ "?, −?̅$ , B$ # + 8$ × @J "?, ?̅ $ , B$ #.

2.11

In addition, empirical adjustment factors were introduced for each of these parameters, as shown
in Equation 2.11, to facilitate fine tuning the model to in-air and in-water measurements as in,
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8"?# = L 8( × MNO × @( P?, ?̅( × ME̅ O , B( × MGO Q,

2.12

(RI

where n is the number of Gaussians needed to model the source, in this case 3, and MNO , ME̅O , and
MGO are the empirical adjustment factors to the electron charge, the mean, and the width

parameter of each source Gaussian, respectively. 8( is similar to 8 as described in Equation 2.6
but only represents the number of photons produced in each Gaussian given by,
8( = 9 × :( ,

2.13

where 9 is as was defined in Equation 2.7 and :( is the number of electrons incident on the target
that contribute photons to Gaussian i.

The photon fluence, "?, S#, may be calculated according to,
1
"?, S# = L 8( ×
,
4DUV"?, S#WX


2.14

(RI

where r is the distance (Euclidean-norm) from the centroid of the source Gaussian to the point of
calculation, or

V = Y"? − ?̅ #$ + "S − S̅#$ ,

2.15

where ?̅ and S̅ define the Gaussian centroid coordinates in the ? and S planes, respectively. The
exponent p is the parameter that describes how quickly the fluence falls off with distance from

the source and is empirically found (See Section 3.1). The mean position of the source Gaussian
on the z-axis, for the purposes of the calculation of V, is equal to the z-axis location of the virtual

photon point source. The virtual photon source is the virtual point source from which the photon
intensity appears to originate and approximately corresponds to the location of the target in the
treatment head (Svensson & Brahme, 1996).
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2.1.3 Collimated Primary Photon Fluence
The collimated primary photon fluence is a modification of the un-collimated primary
photon fluence, representing only those photons which contribute to primary dose. This
component of photon fluence was expressed as


 "?, S# = L Z( × @,( ?, ?̅,( "S#, B,( "S# [ × \"?, S#,

2.16

(

where n=3, ( is from Equation 2.14, the form of @,( ?, ?̅,( "S#, B,( "S# is given by Equation
2.9, and \"?, S# represents the off-axis shape caused by the black body collimation of the final

field-defining aperture, which is depicted in Figure 2.1.

Figure 2.1 – Illustration of the photon linac head. Simplified diagram of a linac head where the
secondary collimators define the final field-defining aperture. The distances involved in
modeling the various absorbed dose components are also indicated.
@,( ?, ?̅,( "S#, B,( "S# is the un-collimated fluence Gaussian projected to the plane of

calculation. This projection was performed from the location of the effective source to the
calculation plane using similar triangles or,
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?̅,( "S# = ?̅( ×
and,

= + 8]"S#
,
=

B,( "S# = B( ×

= + 8]"S#
,
=

2.17

2.18

where d0 represents the distance from the effective source to the virtual source and SPD(z)
represents the distance from the effective source to the calculation plane. The effective source is
the representation of the lateral extent of the distributed photon source which is projected with
SPD from the location of the virtual source (Svensson & Brahme, 1996). The z-axis location of
the effective source was considered to be z=0 for the coordinate system used in this study.

\"?, S# models the black body absorption of primary photons by secondary collimators as

shown in Figure 2.2. The penumbral shape was mathematically represented by a cumulative
normal function, which is defined as the integral of a normalized Gaussian function, or
^_`Va"?, ?̅ , B# =

1

√2DB



E

0H

"E0E̅ #F

0
> $GF ?,

2.19

where ?̅ and σ are the mean and standard deviation of the Gaussian, respectively, and will be
described by Equations 2.20-2.22, below. Based on this definition, the magnitude of the
cumulative normal function ranges from 0 to 1.

The mean of this cumulative normal function in the collimated fluence model, ?̅ "S#, is

equal to the projected location of the collimator edge at the depth of calculation,
?̅ "S# = ? ×

8]"S#
,
8

2.20

where ? is the physical off axis position of the secondary collimator, 8]"S# was previously
defined, and SDD is the effective source to diaphragm distance where the diaphragm, in this

case, is the secondary collimator. These distances are depicted in Figures 2.1 and 2.3.
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Figure 2.2 – Illustration of the black body collimation of primary photon fluence. Diagram
showing the effect of black body absorption by the secondary collimator on the primary photon
fluence.

Figure 2.3 – Photon source and distances to the collimator and dose calculation point. Diagram
showing the distances involved in determining the mean location and width parameter of the
cumulative normal corresponding to the CAX Gaussian.
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The width parameter of the primary cumulative normal corresponds to the effective

source size, Bb , and was estimated as the electron-charge-weighted average of the width
parameters of the three un-collimated primary photon sources, or
Bb

∑(RIdPB( × MGO + ?̅( × ME̅ O Q × :( × MNO e
=
∑(RI :( × MNO

2.21

where B( , MGO , ?̅ ( , ME̅O , :( , and MNO are as previously defined in Equations 2.12 and 2.13. This
width parameter was then projected to the plane of calculation by similar triangles, or,
Bb "S# = Bb ×

"8]"S# − 8#
,
8

2.22

where the distances SPD and SDD were previously defined.

The left field edge was represented by a single cumulative normal function. The right
field edge, on the other hand, was represented by the complimentary cumulative normal, or,
^^_`VaP?, ?̅ "S#, Bb "S#Q = 1 − ^_`VaP?, ?̅ "S#, Bb "S#Q ,

2.23

where ?̅ "S# and Bb "S# are as defined in Equations 2.20 and 2.22.

The shape of the primary photon fluence after black body absorption by the right and left

collimators is then,

\"?, S# = ^_`VaP?, −?̅ "S#, Bb "S#Q × 1 − ^_`VaP?, ?̅ "S#, Bb "S#Q .

2.24

It should be noted that for the linac with which this model was developed, the secondary
collimator as indicated in Figure 2.1 was different in the in-plane and cross-plane directions.
Specifically, the jaw was the secondary collimator in the in-plane direction, and the MLC served
this purpose for the cross-plane direction.
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2.1.4 Absorbed Dose in Air from Collimated Primary Photon Fluence
The component of the total absorbed dose deposited by the collimated primary photon
fluence was modeled in air as



"?, S# =  "?, S# ×  
,'()
×  ,
  ,'()

2.25

where  "?, S# is the collimated primary photon fluence (Equation 2.16) and the final two terms
are part of the fluence-to-dose conversion (Section 2.1.1). Substituting Equation 2.16 into
Equation 2.25, we obtain

"?, S#
,'()



= Lf
(

8( × @,( "?, S#

g × \"?, S# ×  
×  ,
X
4DUV( "?, S#W
  ,'()

2.26

where V( "?, S# corresponds to the Euclidean-norm between ?̅( and a calculation point defined by
its x and z coordinates, and p is the exponent governing the divergence of the primary fluence.
2.1.5 Absorbed Dose in Water from Collimated Primary Photon Fluence
The model for absorbed dose from primary photons in water was based on the model for
that in air. Specifically, the model described in Section 2.1.4 was modified to additionally take
into account attenuation in water, or,

,5

8( × @,( "?, S#

"?, S# = L f
× <h(,5 "?, #g × \"?, S# ×   ×  ,
X
4DUV( "?, S#W
  ,5


2.27

(RI

where <h(,5 "?, # is the photon transmission factor.

<h(,5 "?, # represents the fraction of the primary fluence incident on the water phantom

that was transmitted through water to the depth of calculation. This was modeled as simple

exponential attenuation of the primary photon fluence in water to the point of calculation as in,
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<h(,5 "?, # = >?iU−5 ∙ ( "?# ∙ M5 W,

2.28

where μw is the linear attenuation coefficient of water, ( "?# is the oblique depth in water, and
M5 is an empirical adjustment parameter included to reduce systematic uncertainties in the

estimated mean linear attenuation coefficient, the selection of which will be discussed in more
detail later (See Section 2.1.14).
μw was determined using National Institute of Standards and Technology (NIST) data

tables (Hubbell & Seltzer, 2011). These tables list attenuation coefficients for narrow beam
geometry as a function of photon energy. This value was selected for the estimated mean photon
energy of  = 2 MeV (See Section 2.1.1).

( "?, S# depends on the locations of both the calculation point within the phantom and the

photon source as modeled in Equation 2.12. Figure 2.4 depicts the calculation of ( "?# for an
example calculation point. The corresponding angle, k( "?, S#, was calculated by
k( "?, S# = tan0I

|? − ?̅ ( |
,
8]"S#

2.29

where ?̅ ( and SPD(z) are as previously defined. Using this, the oblique depth in water was
calculated as,

( "?, S# =


,
cos k( "?, S#

2.30

where d is the perpendicular depth in water of the calculation point, as depicted in Figure 2.4.
Thus far, we have treated the collimators as black body absorbers when computing
fluence and dose in the primary field and penumbral regions. Next we will calculate the leakage
radiation emanating from the collimators and the absorbed dose which it deposits, taking into
account attenuation in these devices.
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Figure 2.4 – Illustration of the oblique depth in water. Diagram depicting the oblique depth in
water, ( , and all distances involved in the calculation of this quantity.
2.1.6 Un-Attenuated Leakage Photon Fluence

The un-attenuated leakage photon fluence represents the fluence of photons contributing
the leakage component of the total absorbed dose. This fluence was modeled as


 "?, S# = L Z( × @,( ?, ?̅,( "S#, B,( "S# [ × r"?, S#,

2.31

(

where _ was defined in Equation 2.12, ( and @,( ?, ?̅,( "S#, B,( "S# are the same as in

Equation 2.14, and r"?, S# represents the percentage of photons that are transmitted through an
infinitesimally thin secondary collimator as a function of x, as depicted in Figure 2.5. For

simplicity, in our leakage model we replaced three source Gaussians with three point sources
located at the mean locations of the original source Gaussians and represented by


where r"?# is as before.

 "?, S# ≈ LU( W × r"?, S#,
(
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2.32

Figure 2.5 – Off-axis shape of un-attenuated leakage photon fluence, A(x). Diagram depicting
the shape, r"?#, of the un-attenuated leakage photon fluence as resulting from an infinitely thin
collimator as a function of off-axis position x.
In essence, r"?, S# simply suppresses the leakage radiation inside the primary beam.

Thus, attenuation of fluence by collimators was not yet taken into account (this will be discussed

in Section 2.1.7). By definition, r"?, S# has a magnitude of 0 inside the treatment field where no

collimation is present, and 1 outside of the treatment field where photons reaching that

calculation point from the source must traverse collimation. r"?, S# was modeled with a

combination of cumulative normal functions (See Equation 2.19). Thus, the model for the offaxis shape of the leakage photon fluence was given by

r"?, S# = 1 − ^_`VaP?, −?̅ "S#, Bb "S#Q × ^_`VaP?, ?̅ "S#, Bb "S#Q,

2.33

where ?̅ "S# is as was defined in Equation 2.20 and Bb "S# is calculated by Equation 2.22.
2.1.7 Absorbed Dose in Air from Un-Attenuated Leakage Photon Fluence

The absorbed dose deposited by the un-attenuated leakage photon fluence is known as the
leakage absorbed dose. This was modeled in air as
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"?, S#
,'()



w

= L t( × u <h(,v "?, S#x × r"?# × 
(RI

vRI



× 
  ,'()
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8(

"?,
= Lt
×
u
<h
S#
x
×
r"?#
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×  ,
(,v
4DUV( "?, S#Wy
  ,'()

where n, Si, V( "?, S#, 



(RI




 ,'()

w

vRI

, and  are defined in earlier sections (see Sections 2.1.1 and

2.1.2), and the exponent q governs the divergence of the leakage photons. The product over k=1
to m represents the attenuation through all m attenuating layers (e.g., jaw, MLC, primary

collimator), and <h(,v "?, S# is the transmission factor through each layer.

<h(,v "?, S# is expressed differently depending on the attenuating layer. The secondary

collimator may be varied to define the field size and shape to be delivered to the patient. The

primary collimator, on the other hand, is a stationary collimator which is slightly larger than the
largest field size the linac is capable of delivering. This means that the primary collimator is
located further from the CAX than the secondary collimator for all possible field sizes. Due to
these properties, the general effect of the primary and secondary collimators on the transmitted
fluence is depicted in Figure 2.6.

<h(, "?, S# is the transmission factor for the secondary collimator (SC) and was

calculated as

<h(, "?, S# = >?id− ∙ z{{,(, "?, S# ∙ M e,

2.35

where μSC is the effective linear attenuation coefficient of the secondary collimator, z{{,(, "?, S#
is the effective thickness of the secondary collimator for each point source, and αSC is an

empirical adjustment parameter to reduce the systematic uncertainty in μSC.
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Figure 2.6 – Schematic illustration of the effect of two laterally staggered attenuating layers.
Plot of <h(,v "?, S# after two laterally staggered attenuating layers where ? is the projected
location of the secondary collimator in the plane of calculation and ? is that of the primary
collimator.
z{{,(, "?, S# takes into account oblique angles using,
z{{,(, "?, S# =

z
,
cos k( "?, S#

2.36

where tSC is the thickness of the secondary collimator as defined by the manufacturer and
k( "?, S# was calculated using Equation 2.29.

It should be noted that the projected lengths of the secondary collimators for the linac

used were found to extend beyond |?| > 40 cm, the maximum off-axis distance considered in

this study. Also, the only difference in z{{,(, "?, S# for each point source is due to the different
lateral mean source locations, which lead to slightly different oblique path-lengths through the
collimator.

<h(, "?, S# denotes the primary collimator (PC) transmission factor and is slightly more

complicated than that for the SC. The extra complexity is in part due to the fact that, unlike with
20

the jaws and MLCs, the effect of the PC is not present everywhere that the leakage fluence is
non-zero, as was shown in Figure 2.6. Additionally, the drop in absorbed dose from attenuation
in the primary collimator is characterized by a penumbral width caused by the finite effective
source size. Thus, <h(, "?, S# was modeled according to,

<h(, "?, S# = 1 − rh(, "?, S# × ^_`VaP?, ?̅ , Bb "S# × M

,G Q,

2.37

where rh(, "?, S# is the PC attenuation factor, ?̅ is the projected location of the PC found
using similar methods as shown by Equation 2.20, Bb "S# is the width parameter of the
effective source projected about the PC using Equations 2.21 and 2.22, and M

,G

is an empirical

adjustment factor.

rh(, "?, S# represents the fraction of incident radiation that was attenuated by the

primary collimator, or

rh(, "?, S# = 1 − >?id− ∙ z{{,(, "?, S# ∙ M e,

2.38

where μpc is the mean linear attenuation coefficient of the primary collimator, z{{,(, "?, S# is

the effective thickness of the primary collimator, and αpc is an empirical adjustment parameter.
Unlike the secondary collimator, the primary collimator is shaped in such a way that as the offaxis position increases, the effective thickness of the collimator decreases, as shown in Figure
2.7. Thus, the effective thickness for the primary collimator was calculated as
z{{,(, "?, S# =

}
,
sin k( "?, S#

2.39

where } is the width of the primary collimator, and k( "?, S# is calculated using Equation 2.29,
which are both depicted in Figure 2.7.
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Figure 2.7 – Illustration of the primary collimator effective thickness. Diagram depicting the
shape of the primary collimator and the effective thickness for an off axis calculation point
P(x,z).
It should be noted that linac-produced photon beams are polyenergetic; therefore, the
mean linear attenuation coefficients for the secondary and primary collimators were deduced
using data from NCRP Report No. 151 (2005). This was done using tenth value layers (TVLs)
for lead, which are tabulated for typical linac, polyenergetic photon energy spectra. While the
primary and secondary collimators of linacs are not typically made of lead, this was the material
for which data were available with the closest atomic number to that of the collimators (personal
communication, Elekta, Stockholm). First, a density correction was applied to the published
TVL for lead in order to approximate the TVL for the specific alloy present in the collimator as
in
<v = <


,
v

where <v and < represent the TVL of the attenuating layer material and lead,

2.40

respectively, and  and v are the mass densities of lead and the attenuating layer material
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(personal communication, Elekta, Stockholm), respectively. Next, the linear attenuation
coefficient, v , was found from the density corrected TVL using
1
10
v = −
.
<v
ln

2.41

2.1.8 Absorbed Dose in Water from Un-Attenuated Leakage Photon Fluence
Up to this point the dosimetric effect of attenuation in water for leakage radiation was not
modeled. This effect can be taken into account by modifying Equation 2.34 to become

,5

where 





"?, S# = L ( × u <h(,v "?, S# × r"?# ×   × 
  ,5


(RI

w

vRI
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8(

= L
× u <h(,v "?, S# × r"?# ×   ×  ,
y
4DUV( "?, S#W
  ,5


(RI

 ,5

w

vRI

was previously defined (See Section 2.1.1) and a = a + 1 to allow for the

transmission factor of an additional attenuating layer, i.e., water, given by <h(,5 "?, #.

The additional transmission factor, <h(,5 "?, #, represents the fraction of incident leakage

radiation that was transmitted to the depth of the calculation point in water and is as was given
by Equation 2.28.

Thus far, absorbed doses that result from those photons originating at the electron target
have been considered. More specifically, scattered radiation emanating from other sources, e.g.,
those located elsewhere in the linac head and in the patient, have been neglected.
2.1.9 Virtual Sources of Scattered Radiation
The absorbed dose due to scattered radiation is

 =  +  ,
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2.43

where  is the absorbed dose from photons scattered in the treatment head, and  is the

absorbed dose from radiation scattered in the phantom.

We modeled scatter radiation as emanating from a pair of virtual sources, as shown in
Figure 2.8. These sources are separate from the source model used for primary and leakage
radiations.

Figure 2.8 – Schematic illustration of virtual sources of scattered radiation. Diagram of the
various virtual sources in the scattered dose portion of the model.
2.1.10 Absorbed Dose in Air from the Virtual Source of Head-Scattered Radiation
The virtual source of head-scattered radiation is located at the downstream edge of the
flattening filter and on the CAX (McKenzie & Stevens, 1993), as shown in Figure 2.8. The
absorbed dose in air from the virtual source was modeled as

"?, S# =  "S # × U)
,'()

I

 "#W

× @ "?, S#,

2.44

where  "S # is the head scatter reference absorbed dose magnitude defined on the CAX at

the flattening filter, V "S# is the Euclidean norm between this virtual source and the calculation
plane calculated using Equation 2.15, the exponent s governs the divergence of head-scattered
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radiation, and @ "?, S# represents the lateral Gaussian shape. Unlike the Gaussian defined in

Equation 2.9, @ "?, S# is not normalized or,

and thus

@ "?, S# =

"E0E̅ #F

0 F
> $G "# ,

@ "0, S# = 1.

 "S # is related to the size of the field incident on the phantom. As the field area

2.45

2.46

increases, more of the head-scattered radiation will be able to reach the phantom. As such, this
dependence was modeled as a power law, or,

 "S # = 9, × hrI/ ,

2.47

where FA denotes the field area defined at the depth of calculation, the exponent u is a parameter

governing how strongly this amplitude varies with changes in field area, and 9, is a constant

of proportionality. However, this relationship is only true up to some limit. Eventually, the field
size will reach a point where all of the head scatter source is visible, and  "S #, the reference
absorbed dose, will no longer increase with the field size. Algorithmically, this limit was,
hr > hrw'E → hr = hrw'E
hr < hrw'E → hr = hr

2.48
2.49

where hrw'E is the empirical cut-off field area defined at the depth of calculation, the selection
of which will be discussed in more detail later (See Section 2.1.14).

@ "?, S# denotes the Gaussian shape of the head scatter dose. This Gaussian is

characterized by a mean located on the CAX and a width parameter at the depth of calculation of

B "S#. The projected width parameter is,

B "S# = B "0# ×

"8]"S# − 8hh#
,
"( − 8hh#
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2.50

where B "0# is the head-scatter effective source size, 8]"S# has been previously defined,

SFFD is the effective source-to-flattening-filter-distance, and diso is the distance from the

effective source to isocenter, all of which are indicated in Figure 2.1. Note that the quantity in
the numerator represents the distance from the virtual source to the calculation plane, while the
denominator represents the virtual source to isosentric plane distance.
The width parameter of the head-scatter effective source size is related to the location of
the secondary collimator and was modeled as a power law, or

B "0# = 9,G × U? "0#WI/ ,

2.51

where ? "0# is the off-axis location of the secondary collimator (SC) projected to the isocentric
plane, the exponent v governs how strongly the width parameter varies with lateral SC position,

and 9,G is an empirical constant of proportionality.

2.1.11 Absorbed Dose in Water from the Virtual Source of Head-Scattered
Radiation
The absorbed dose in water due to head-scattered radiation was calculated according to

"?, S# = ,'() "?, S# × <h,5 ,
,5'6)

where ,'() "?, S# is from equation 2.44 and <h,5 is the transmission factor for head-

2.52

scattered photons through water. This transmission factor was given by
<h,5 = >?iU−5 ∙  ∙ M W,

where μw is as was described in Section 2.1.5,  was defined in Equation 2.30, and αHS is an

2.53

adjustment parameter.  "?, S# was calculated using equation 2.30 but with all distances

measured from the head scatter virtual source.

Thus far all major sources of radiation that emanate from the treatment head in some
capacity have been considered. Absorbed dose from radiation that scatters in the phantom has
been neglected and will be considered next.
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2.1.12 Absorbed Dose in Water from the Virtual Source of Phantom-Scattered
Radiation
The virtual source of phantom-scatter radiation is shown in Figure 2.8. The phantom
scatter dose, by definition, only exists when a phantom is present. Thus, this portion of the
model was developed exclusively for calculating dose in water. The dose due to phantomscattered radiation was based on methods proposed by Newhauser (2011, personal
communication) and used by Zhang et al. (2011) and Taddei et al. (in review). This portion of
the dose was expressed as

"?, #
,5'6)

=  "#d\"# × @,I "?# × <h,I "?# + P1 − \"#Q × @,$ "?#

2.54

× <h,$ "?#e,

where r "# is the integral absorbed phantom scatter dose, \"# is a partitioning factor ranging
between 0 and 1 to apportion the two component Gaussians, @,I "?# and @,$ "?# are each unnormalized Gaussians, and <h,I "?# and <h,$ "?# are the corresponding transmission factors

in water.

r "# depends on the field area that was incident upon the phantom as well as the depth

of the calculation in water. This was modeled as a power law relationship, or
r "# = 9, × hr"0#I/5 × I/ ,

2.55

where 9, is an empirical constant of proportionality, hr"0# is the area of the treatment field
projected to the isocentric plane, the exponent w governs the dependence on FA, d is the

perpendicular depth of the calculation plane as indicated in Figure 2.4, and the exponent b
governs the dependence on depth.
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@,I "?# and @,$ "?# are the components of the total double Gaussian and follow the

function detailed in Equation 2.45. The Gaussians are centered on the CAX "?̅ = 0# with width

parameters B,I and B,$ , respectively.

@,I "?# is the narrower of the two Gaussians. The width parameter, B,I , was modeled

as proportional to the field size as in

B,I = 9,G,I × U? "0#WI/{ ,

2.56

where κPS,σ is an empirical constant of proportionality, U? "0#W was defined in Equation 2.51,
and the exponent f governs the dependence on field edge location.

@,$ "?# represents the wider of the two Gaussians. The width parameter, B,$ , was

modeled as a function of the field area as in

B,$ = 9,G,$ × hrI/

2.57

where 9,G,$ is an empirical constant of proportionality, hr is the area of the treatment field

projected to the depth of calculation, and the exponent h governs the dependence on field area.
<h,( "?# models attenuation of the patient scattered radiation according to
<h,( = >?id−5 ∙ ? ∙ M,( e,

2.58

where μw was described in Section 2.1.5, x is the off-axis distance of the calculation point, and
αPS,i is an empirical adjustment parameter. This adjustment parameter corrects for systematic
bias caused by errors in the estimation of average energy of the phantom scattered radiation.
This parameter was given independent values for each phantom scatter Gaussian. By definition,
one Gaussian deposits dose, on average, closer to the CAX than the other and, thus, we do not
assume the average energy of photons depositing dose in each Gaussian is equal.
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2.1.13 Training Data
The analytic model was trained using measured profiles of photon doses. These profiles
were measured both in air and in a water-box phantom. The measurement conditions for all
training data are listed in Table 2.1. Water-tank measurements used to train this model were
taken from a study by Kaderka et al. (2012). These measurements were performed on an
electron linac (Elekta SL25, Stockholm) at Universitätsklinikum (KGU) in Frankfurt, Germany
operated at 6 MV. Photon doses were measured using a diamond detector (60003 PTW,
Freiburg) in a water tank (PTW, Freiburg). Five lateral profiles were available (Chiarra LaTessa,
personal communication, October 2012) measured in both the in-plane and cross-plane directions
for two different square field sizes and at two depths in the phantom. One additional profile was
measured at our institution to supplement the data from KGU as indicated in Table 2.1. In-air
photon doses were measured with a farmer-type ion chamber (PTW, TN30013, S/N:0579,
Freiburg) for fields produced by an electron linear accelerator (Elekta Synergy, S/N:151892,
Stockholm) at Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana. Measurements
were recorded with all collimating apertures in their largest setting, 40x40 cm2. Profiles were
scanned in both the in- and cross-plane directions at 4 source-to-measurement-plane distances
(SPDs) as well as along the CAX. In addition to this, a set of measurements was taken at the
same two field sizes and SPDs as were represented in the water-tank measurements, but with the
water-tank left empty.
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Table 2.1 – Measurement conditions for profiles used to train the dose model. The
measurement conditions for the profiles used to train the dose model are listed, including the
field size, source-to-surface distance (SSD), depth, source-to-measurement-plane distance
(SPD), and scan direction. The measurement conditions indicated by * represent the reference
conditions selected for this study.
Water-Phantom
Field Size (cm²) SSD (cm) Depth (cm) Profile
In-Plane
100
1.5
Cross-Plane
5x5
In-Plane
100
10
Cross-Plane
In-Plane
10x10 *
100*
1.5*
Cross-Plane
In-Air
SPD (cm)
Field Size (cm²)
Profile
In-Plane
101.5
Cross-Plane
5x5
In-Plane
110
Cross-Plane
In-Plane
10x10 *
101.5*
Cross-Plane
In-Plane
85
Cross-Plane
In-Plane
100
Cross-Plane
40x40
In-Plane
115
Cross-Plane
In-Plane
130
Cross-Plane

Source
Kaderka et.
al. (2012)
This Work
Kaderka et.
al. (2012)
Source

This Work

It should be noted that the in-plane direction refers to measurements that were taken
along the axis parallel to the direction of the bending magnet while cross-plane refers to
measurement profiles perpendicular to the direction of the bending magnet. This naming
convention is illustrated in Figure 2.9. Also, shown in this figure is the secondary collimation
system in which it can be seen that the in-plane secondary collimators are located downstream of
the cross-plane secondary collimators. Additionally, all data measured in this work was
characterized by a much larger dose resolution than that measured by Kaderka et al. and thus, for
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visualization purposes, all plots have been smoothed in the low dose region using a moving
average filter over a range of 3 cm.

Figure 2.9 – Planar naming convention. Diagram of a general linac head and bending magnet
showing the definition of in-plane and cross-plane directions.
2.1.14 Parameter Selection
Selected model parameters were determined with the use of a gradient search algorithm.
This algorithm minimized the magnitude of the sum of local percent differences between
measured and calculated dose values, while model parameters were allowed to vary. This
algorithm was used by optimizing the local relative dose differences for groups of profiles
simultaneously so that fitted parameters are applicable to multiple profiles. Once optimizations

were complete, it was verified that the root mean square (RMS) local relative difference, b , for
each plane was ≤ 10%. This was calculated as
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1
$
8"b # =  Ld"b #( e,
_


2.59

(RI

where n is the number of data points and b is the local relative difference, or
"b #( =

 "?( # − w "?( #
,
w "?( #

2.60

in which  "?( # is the calculated dose at the off-axis location ?( , and w "?( # is the measured
dose at that same location.

The empirical parameters involved in the model for the un-collimated primary photon
fluence were found by fitting to only the in-air, open field (40x40 cm2) measured training data
because this was the best approximation of an un-collimated source measurement. The mean of
the central source Gaussian was assumed to be located on the CAX while all other empirical
parameters were allowed to vary independently in the in-plane and cross-plane directions. This
was done to allow for the possibility of a non-radially symmetric source. Additionally, the fit
was done with the constraint that the magnitude of the source on the CAX must be the same in
both the in-plane and cross-plane directions.
The empirical adjustment parameters for the model for absorbed dose from the collimated
photon fluence as well as absorbed dose from the un-attenuated leakage fluence were found
using the gradient search algorithm to simultaneously fit to all training data measured in water.
Again, empirical adjustment parameters were found independently in each plane.
In order to better isolate the parameters for head-scatter absorbed dose from those for
phantom-scatter absorbed dose, the empirical adjustment parameters involved in the model for
absorbed dose from head-scattered radiation were found by simultaneously fitting all profiles
measured in air, with the exception of the 40x40 cm2 field data. In this way, scatter from the
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phantom was excluded. One additional parameter was included specifically to calculate
absorbed dose in a water-phantom from head-scattered photons, the empirical adjustment

parameter to the linear attenuation coefficient of water, M . This parameter was found by

simultaneously fitting all water-phantom training data and allowing only this parameter to vary.
Much like the previously-outlined portions of the model, independent values were found in the
in-plane and cross-plane directions.
The empirical parameters describing dose due to phantom-scattered photons were found

by simultaneously fitting all profiles measured in water. The dose due to phantom-scattered
photons is most affected by the size and shape of the radiation field incident on the phantom
rather than specific linac head characteristics. Thus, unlike with the previously discussed
absorbed dose models, each parameter was directly applied to all data in both the in-plane and
cross-plane directions and all depths. The only exception to this was for the partitioning factor,
C. This parameter was given independent values for each depth of calculation but still shared
between calculations in the in-plane and cross-plane directions.
2.2 Model Validation
2.2.1 The Gamma Index
The model was validated using an approach based on a one-dimensional gamma index
analysis between measured and calculated absorbed doses. The gamma index is a convenient
and widely used method to incorporate both dose difference as well as distance to agreement
criteria in a single factor (Low, Harms, Mutic, & Purdy, 1998). This combination is important
because large dose differences often occur in areas of steep dose gradient due to slight offsets
between measured and calculated profiles.
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Traditionally, the gamma index incorporates two criteria: local dose difference, Δ, and

distance to agreement, Δ. In general, the gamma index draws an ellipse around each measured
data point. This ellipse is characterized by major and minor axes equal to Δ and Δ, as

depicted in Figure 2.10. The index then tests whether a calculated data point can be found within
this ellipse. Due to the need to adequately validate the model in this work over a wide dynamic
range of dose magnitudes, we introduced two different sets of validation criteria, specifically, for
the in-field and out-of-field regions of the profiles.

Figure 2.10 – Gamma index ellipse diagram. Illustration of a measured data point and the use
of the agreement criteria, Δ and Δ, to define an elliptical region of agreement around that
data point (Low, Harms, Mutic, & Purdy, 1998).
Positions were classified as in-field or out-of-field following the methodology proposed
by Howell et al. (2010), or

w "?( , S#
> 5% → ?( _ − h>
w "0, w'E #

w "?( #
≤ 5% → ?(  z − `¡ − h>
w "0, w'E #

where w "?( # was defined in Equation 2.60. Data points determined to be in-field were

2.61

2.62

compared to a relative dose criterion, Δb while out-of-field data were compared to an absolute

dose criterion,  .
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The gamma index was calculated following methods of Low et al. (1998). First ¢ was

found for every combination of measured and calculated dose values. ¢ is defined as
V $ "?w , ? #  $ "?w , ? #
¤
Γ"?w , ? # =
+
,
¥ $
¥$

2.63

where ?w and ? are the locations of measured and calculated dose values, respectively. Note

that Γ"?w , ? # was found for every possible combination of measured and calculated doses and

thus, ?w ≠ ? . The first ratio under the square root contains the distance-to-agreement (DTA)

comparison where V"?w , ? # represents the distance between the measured and calculated dose

values being compared and ¥ is the DTA criterion. The second ratio performs the dose

difference (DD) comparison where "?w , ? # represents the DD between measured and

calculated doses, and ¥ is the dose agreement criterion. Each of these values is depicted in
Figure 2.11.

Figure 2.11 – Gamma index components. Diagram showing the various distances involved in
calculating the gamma index including the distance between measured and calculated dose
values, V"?w , ? # and the dose difference between calculated and measured dose values,
"?w , ? #.
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For all ?w determined to be in-field, a relative DD was computed as
b "?w , ? # =

 "? # − w "?w #
,
w "?w #

2.64

where  and w are as defined in Equation 2.60 and, ? and ?w were defined in Equation 2.63.
This relative DD value was then compared to ¥b .

For ?w determined to be out-of-field, the absolute DD was calculated using,
 "?w , ? # =  "? # − w "?w #,

2.65

where all parameters were defined in Equations 2.60 and 2.63. This absolute DD value was then
compared to the criterion ¥ .

The DTA portion of this analysis remained the same for both in-field and out-of-field

comparisons. More specifically,

V"?w , ? # = |?w − ? |∀¨?w ©.

2.66

ª"?w # = a_¨Γ"?w , ? #©∀¨? ©.

2.67

The final gamma index array, ª, was then found by

When found in this way, ª"?w # ≤ 1 indicates that a calculated data point was found within the
ellipse characterized by ¥ and Δ drawn around w "?w #. When this is the case, ?w is
considered as passing the gamma index comparison. On the other hand, a final value of

ª"?w # > 1 indicates that a calculated dose value was not found within this ellipse and "?w #

fails. The gamma index was calculated for all validation profiles to test if the model produced a

ª"?w # ≤ 1 for 90% or more of measured data points. This criterion was selected because it is
the value that is in common clinical use (Nelms & Simon, 2007).
2.2.2 Validation Conditions

The Δb agreement criterion was set at 10%. This value was only applied in the in-field

portion of the beam, where the measured dose was greater than 5% of the dose on the CAX.
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10% was selected as a goal for improving current epidemiological calculation accuracy which
was reported to agree with measured doses within 20% (Stovall, et al., 2006).

Δ was the absolute dose comparison criterion for the out-of-field region. This region is

characterized by very low doses for which small absolute differences result in very high relative

differences. Δ was set at 2 mGy/Gy and was selected to be approximately twice the ionization
charge quantization error in measurements in this region, which in this case was 1.08 mGy/Gy.
Figure 2.12 shows an absorbed dose profile measured in water under the reference
conditions along with the upper and lower dose limits corresponding to the gamma index criteria.
In this figure, all doses to the left of the dashed line are considered in the treatment field and
thus, the relative criterion range is depicted. All doses to the right of this dashed line are outside
of the treatment field and are surrounded by the absolute criterion interval.
Because of the vast differences in detector response between the high and low dose

regions, different Δ criteria were selected for use with each of the Δb and Δ criteria. The

Δb criterion was set at 3 mm because this is the value that is in common clinical use (Nelms &

Simon, 2007). The criterion used for Δ was 10 mm. This large increase was necessary for the
presence of the region of steep dose gradient due to the primary collimator in the far-from-field
region where charge digitization errors were a most problematic. (Δ may approach the
clinically used 3 mm criterion with more sensitive charge measurements). Figure 2.13 shows a
measured dose profile along with the upper and lower limits based on the relative and absolute
distance criteria.
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Figure 2.12 – Absolute and relative dose criteria ranges. Measured dose «

«

¬®"¯°±#

versus off-axis

position x in water for a 10x10 cm2 treatment field at a depth of 1.5 cm along with the upper and
lower dose limits for both in-field and out-of-field regions.
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Figure 2.13 – Distance to agreement criteria intervals. Measured dose «

«

¬®"¯°±#

versus off-axis

position x in water for a 10x10 cm2 treatment field at a depth of 1.5 cm along with the upper and
lower distance to agreement limits.
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2.2.3 Validation Data
The model developed in Section 2.1 was validated against data measured independently
of the training data. The measurement conditions for the validation data are listed in Table 2.2.
Photon doses were measured both in air and in a water-tank phantom (IBA Dosimetry, Blue
Phantom2, S/N:14236, Bartlett, TN) with the use of a farmer-type ion chamber (PTW, TN30013,
S/N:0579, Freiburg). Fields were produced by an electron linear accelerator at Mary Bird
Perkins Cancer Center in Baton Rouge, LA, using a clinically commissioned and calibrated linac
(Elekta Synergy, S/N:151892, Stockholm). Profiles in the in-plane and cross-plane directions
were measured for several square and rectangular field sizes, SSDs, and depths.
To facilitate a systematic model validation, for each non-reference profile, only one
characteristic was chosen to differ from the reference conditions. The cells containing # in Table
2.2 indicate that which was different from the reference conditions for each profile. It should be
noted that the rectangular fields were chosen to have the same field area, FA, as the reference
conditions but a different aspect ratio.
2.3 Uncertainty Analysis
In order to accomplish specific aim three (see Section 1.3), it was necessary to estimate
the uncertainty associated with the developed dose model. This was done using standard error
propagation techniques under the assumption that all model parameters were uncorrelated. More
specifically, the following equation was used:
B{

$

¡ $ $
¡ $ $
¡ $ $
=   BE +   B³ +   B + ⋯
?
²
S

where the notation B( indicates the uncertainty in the argument i and
derivative of f with respect to the argument i.
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µ{
µ(

2.68

represents the partial

Table 2.2 – Measurement conditions for profiles used to validate the dose model. List of
measurement conditions for profiles used to validate the dose model, including field size, aspect
ratio, source-to-measurement-plane distance (SPD), source-to-surface distance (SSD), depth, and
measurement direction. The reference conditions are indicated by * while those indicated with #
represent those characteristics that differed from the reference conditions for each field
configuration.
In-Air
SAD (cm)

Field Size
(cm²)

Aspect
Ratio

SPD (cm)

100*

10x10 *

1:1*

101.5*

100

10x10

1:1

110 #

100

5x20

1:4 #

101.5

100

20x5

4:1 #

101.5

100

20x20 #

1:1

101.5

Profile
In-Plane
Cross-Plane
In-Plane
Cross-Plane
In-Plane
Cross-Plane
In-Plane
Cross-Plane
In-Plane
Cross-Plane

Water-Phantom
SSD (cm)

Field Size
(cm²)

Aspect
Ratio

Depth (cm)

100*

10x10*

1:1*

1.5*

100

10x10

1:1

10 #

100

5x20

1:4 #

1.5

100

20x5

4:1 #

1.5

100

20x20 #

1:1

1.5

85 #

10x10

1:1

1.5

Profile
In-Plane
Cross-Plane
In-Plane
Cross-Plane
In-Plane
Cross-Plane
In-Plane
Cross-Plane
In-Plane
Cross-Plane
In-Plane
Cross-Plane

For example, the uncertainty in the model for total dose as detailed in Equation 2.1 is
B $ «¶ = B $ «· + B $ «¸ + B $ «¹ ,
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2.69

where the uncertainty in the total dose is equal to the quadrature sum of the uncertainties for each
of the three dose components.
The uncertainty in each dose component was also found using Equation 2.68. Using this,
the uncertainty in absorbed dose from the collimated primary photon fluence was found to be
represented by


B $ «· = L f( ∙ @,( ∙ <h5,( ∙ \ ∙
(

$
$

∙ B   + ( ∙ @,( ∙ <h5,( ∙ \ ∙  ∙ B 



+ ( ∙ @,( ∙ <h5,( ∙
+ ( ∙ <h5,( ∙ \ ∙

2.70

$
$


∙  ∙ B  + ( ∙ @,( ∙ \ ∙
∙  ∙ Bº,O 



$
$


∙  ∙ B»·,O  + @,( ∙ <h5,( ∙ \ ∙
∙  ∙ B¼O  g.



The uncertainty in the absorbed dose from the un-attenuated leakage fluence calculated
with Equation 2.42 is similar to that for the absorbed dose from the primary fluence because both
are based on the un-collimated primary photon fluence and the fluence-to-dose conversion
described in Equation 2.2. The uncertainty in this component of the total dose is
B

$

«¸

$


= L ½( ∙ u <h(,v ∙
∙  ∙ B ¾ + ½( ∙ u <h(,v ∙ r ∙  ∙ B ¾



(

w
v

w

$

v

$



+ ½( ∙ u <h(,v ∙ r ∙
∙ B  ¾ + ½u <h(,v ∙ r ∙
∙  ∙ B¼O ¾


w
v

w
v

2.71

$

$


+ ½( ∙ L <h(,v ∙ r ∙
∙  ∙ BO,¿ ¾ .

w0I
v

The scatter dose was developed in two parts, as described by Equation 2.43 and as such,
the uncertainty in this component of the total dose was also derived in two parts, or
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B $ «¹ = B $ «À¹ + B $ «·¹ ,

2.72

where B is the uncertainty in the absorbed dose from the head-scattered virtual source and B
is that in the absorbed dose from the phantom-scattered virtual source. Each of these were also
found using Equation 2.68 and the uncertainty in the absorbed dose from the head-scattered
virtual source is
B

$

«À¹

=  ∙

1

UV W

$

∙ @ ∙ BÀ¹  +  ∙


+  ∙ @ ∙ <h ∙

1

UV W

1

UV W

$

∙ <h ∙ B»À¹ 


2.73

$

∙ ln V ∙ B 

$
+ P ∙ @ ∙ <h ∙ −Á ∙ V 00I ∙ B) Q .

The uncertainty in the phantom-scattered dose component is

B $ «·¹ = dP\ ∙ @,I ∙ <h,I + "1 − \# ∙ @,$ ∙ <h,$ Q ∙ B·¹ e
+ dr ∙ P@,I ∙ <h,I − @,$ ∙ <h,$ Q ∙ B e

$

$

+ Pr ∙ \ ∙ <h,I ∙ B»·¹,Â Q + Pr ∙ \ ∙ @,I ∙ B·¹,Â Q
$

2.74

$

+ dr ∙ "1 − \# ∙ <h,$ ∙ B»·¹,F e + dr ∙ "1 − \# ∙ @,$ ∙ B·¹,F e .
$

$

The total uncertainty in calculated absorbed dose values was evaluated at four off-axis
positions using the above outlined equations for the reference conditions of a 10x10 cm2 field
measured at a depth of 1.5 cm in a water-phantom with an SSD of 110 cm in both the in-plane
and cross-plane directions. The four positions of interest were selected to span the entire
measurement range. The four positions studied were located on the CAX, at the 5% off-axis
ratio level, 15 cm from the CAX, and 30 cm from the CAX.

42

Chapter 3 Results
This chapter presents the results of this study. Ultimately, it details the findings for the
model of total absorbed dose. First it lists the empirical parameters found to best fit the
measured training data for each portion of the model (3.1). Next it shows the results of the
gamma index analysis on the validation profiles (3.2). Finally, it provides the findings of the
uncertainty analysis performed on calculated absorbed dose (3.3).
3.1 Model Development
3.1.1 Un-collimated Primary Photon Fluence
The un-collimated primary photon fluence was modeled as described in Section 2.1.2 and
all empirical parameters were found as outlined in Section 2.1.14. The un-collimated photon
fluence that best fit the measured training data in the in-plane and cross-plane directions with
Equations 2.12 and 2.14 is shown in Figure 3.1. Table 3.1 summarizes the parameters involved
in the calculation of this source, including the values found to yield the best fit to measured
doses. From Figure 3.1 and Table 3.1 it can be seen that un-collimated fluence parameters were
similar in the in-plane and cross-plane directions, with the cross-plane fluence profile being
slightly wider than that in the in-plane direction. It should also be noted that all of the empirical
parameters in this portion of the model correspond to physical quantities that may, in future
work, be measured or estimated with the use of Monte Carlo simulations.
Figure 3.2 shows the calculated absorbed dose due to this un-collimated photon fluence
for a 40x40 cm2 treatment field, our closest approximation of an un-collimated beam, along with
the corresponding measured dose profile. The secondary axis on this plot shows the local
percent difference. In this plot it can be seen that the relative local dose difference is roughly
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Figure 3.1 – Calculated un-collimated source of photons in the in-plane and cross-plane
direction. Plot of the in-plane and cross-plane calculated un-collimated source of primary
photon fluence at the location of the effective source required to deposit a dose of 1000 mGy/Gy
at a depth of dmax in water, on the central axis.
Table 3.1 – Parameters for the un-collimated primary photon fluence.
Symbol
Description
Charge of electrons incident on the target
:I
contributing photons to the central
Gaussian (C)
Charge of electrons incident on the target
:$
contributing photons to each peripheral
Gaussian (C)
Width parameter of the central Gaussian
BI
(mm)
Width parameter of each peripheral
B$
Gaussian (mm)
Mean location of the central Gaussian
?̅I
(mm)
Off-axis mean location of each peripheral
?̅$
Gaussian (mm)
p
Exponent driving the divergence of the uncollimated photon fluence
;"<= # Photon yield for 6 MeV electrons in
Tungsten

1

From iterative fitting procedure
Assumed
3
(Attix, 1986)
2
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In-Plane
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0
1.13

1.24
0.97
0.216

constant and evenly distributed about 0. This indicates that errors are small and no significant
systematic biases are present.
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Figure 3.2 – Absorbed dose from un-collimated primary photon fluence compared to measured
values. Plot showing the in-plane absorbed dose profile of a 40x40 cm2 field, the closest possible
approximation to an un-collimated source, at an SPD of 100 cm. Normalized dose profile
magnitudes are indicated on the left ordinate and relative local dose differences are on the right
ordinate.
3.1.2 Absorbed Dose in a Water-Phantom from Collimated Primary Photon Fluence
The absorbed dose in a water-phantom from the collimated primary photon fluence was
calculated as detailed in Section 2.1.5. Figure 3.3 shows the calculated primary absorbed dose
found using Equation 2.27 along with a measured total absorbed dose profile. Differences
between in-plane and cross-plane measured and calculated doses were negligible for this portion
of the model and thus, only in-plane profiles are shown. Table 3.2 lists all parameters involved
in the calculation of the absorbed dose in water due to the collimated photon fluence.
In Figure 3.3 it can be seen that the absorbed dose due to the primary photon fluence
accounts for nearly all of the dose deposited inside of the treatment field. The measured
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absorbed dose profile begins to significantly deviate from the calculated absorbed primary dose
around the 5% isodose line, or 50 mGy/Gy. The empirical adjustment parameters to the incident

electron charge, MNO , shown in Table 3.2 were included, and deviated from unity, because :( was

determined from measurements which were performed in air and with a farmer-type ion chamber
while the profiles to which these additional parameters were fit were measured in water with a
diamond detector. Thus, we did not assume that the response of an ion chamber in air was the
same as a diamond detector in water. The empirical adjustment parameters to the width

parameters, MGO were included in order to correct for any loss of spatial resolution due to the
large volume of the dosimeter used to measure the in-air profiles.

Figure 3.3 – Primary absorbed dose model in water compared to a measured total absorbed dose
profile. Plot of calculated primary dose,  , (See Equation 2.27) shown along with an in-plane
absorbed dose profile measured in water for the 5x5 cm2 field at an SSD of 100 cm and a depth
of 1.5 cm.
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Table 3.2 –Parameters for the absorbed dose from primary photon fluence in water.
Symbol
Description
Incident electron charge empirical
MNÂ
adjustment parameter for Gaussian 1
Incident electron charge empirical
MNF
adjustment parameter for Gaussian 2
Width parameter adjustment factor for
MGÂ
Gaussian 1
Width parameter adjustment factor for
MGF
Gaussian 2
Adjustment parameter for the mean of
ME̅ F
Gaussian 2
Adjustment parameter to the µt of water
M5
=

In-Plane
1.24

Cross-Plane
1.20

0.62

1.00

0.79

0.52

0.51

0.74

0.82

1.51
0.77

SSD

Upstream distance from the effective
photon source to the virtual photon source
(mm)
Linear attenuation coefficient of water for
2 MeV photons (1/cm)
Source-to-surface-distance (cm)

100

100

SDD

Source-to-diaphragm-distance (cm)
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37.7

5

6.03
4.942 × 100$

Source
This
Work4
This
Work4
This
Work4
This
Work4
This
Work4
This
Work4
This
Work4
From
Literature5
From
Literature6
From
Literature7

3.1.3 Absorbed Dose in a Water-Phantom from Un-Attenuated Leakage Photon
Fluence
The absorbed dose in a water-phantom due to the un-attenuated leakage fluence was
calculated as described in Section 2.1.8. This calculated dose component is shown for the inplane and cross-plane directions in Figure 3.4, along with absorbed dose measured in a waterphantom for both the in-plane and cross-plane directions. Table 3.3 lists all parameters involved
in the calculation of this portion of the model using Equation 2.42.
From Figure 3.4 it can easily be seen that the leakage fluence deposits the majority of the
dose in the far-from-field region in both planes. Also, the magnitude of dose deposited by

4

From iterative fitting procedure
(Hubbell & Seltzer, 2011)
6
(Kaderka, et al., 2012)
7
(Elekta Digital Linear Accelerator User Manual, 2007)
5
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leakage fluence is roughly equal in the in-plane and cross-plane directions at off-axis distances
smaller than 20 cm and greater than 30 cm. However, the location and spread of the drop in dose
due to the primary collimator is very different between the two directions. This is most likely
attributable to a different average effective source location along the z axis in each the in-plane
and cross-plane directions as well as different source width parameters in each direction. It
should also be noted that while the absorbed dose from the collimated primary photon fluence
accounted for the majority of the total absorbed dose inside the treatment field, and the absorbed
dose from the leakage photon fluence gives the majority of the total absorbed dose far from the
treatment field, these two portions of the model alone do not describe the absorbed dose
deposited in the near-field region.

Figure 3.4 – Absorbed dose from un-attenuated leakage photon fluence compared to total
absorbed dose measured in water. Plot of the calculated absorbed dose from the leakage photon
fluence and measured water-tank total absorbed dose. Measured doses correspond to a 5x5 cm2
field at an SSD of 100 cm and a measurement depth of 1.5 cm in both the in-plane and crossplane directions.
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Table 3.3 – Parameters for the absorbed dose from un-attenuated leakage photon fluence. List
of all parameters involved in the calculation of absorbed dose due to the leakage photon
fluence.
Symbol
Description
M ,G Adjustment parameter for source width
for the leakage fluence attenuated by the
primary collimator
q
Divergence factor for the leakage
photon fluence
Adjustment factor to the µt of the
M
secondary collimator
Adjustment factor to the µt of the
M
primary collimator
Distance from the focus of the primary
8
collimator cone to isocenter (cm)
Adjustment factor for the 8 in each
MÄ«
plane
Linear attenuation coefficient of the

secondary collimator (1/cm)
Secondary collimator thickness (cm)
z
}
?̅ 

Effective attenuation of the primary
collimator
Projected location of the primary
collimator in the isocentric plane (cm)

In-Plane
0.87

Cross-Plane
4.13

Source
This Work8

1.58

1.11

This Work8

1.46

1.85

This Work8

0.32

0.28

This Work8
This Work8

112
1.09

0.87

This Work8

0.77

0.58

7.8

11.2

From
Literature9
From
Literature10
From
Literature9,10
From
Literature10

0.64
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3.1.4 Absorbed Dose from Virtual Sources of Scattered Radiation
The absorbed dose in air from head-scattered photons was calculated as described in
Section 2.1.10. Figure 3.5 shows the absorbed dose due to head-scattered photons calculated
from Equation 2.44, along with total absorbed dose values measured in air. As described in
Section 2.1.14, this portion of the model was first fit in air in order to better isolate the
parameters for head-scatter absorbed dose from those for phantom-scatter dose. In this figure, it
can be seen that the absorbed dose due to head-scattered photons is not the same in each of the

8

From iterative fitting procedure
(NCRP, NCRP Report No. 151: Structural Shielding Design and Evaluation for Megavoltage X- and Gamma-Ray
Radiotherapy Facilities, 2005)
10
Personal Communication, Elekta, Stockholm, Sweden
9
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in-plane and cross-plane directions. The cross-plane direction was characterized by a wider
Gaussian shape than the in-plane direction. This difference is reasonable considering the uncollimated photon fluence was also found to have a wider profile in the cross-plane direction
than in the in-plane direction.

Figure 3.5 – Absorbed dose from head-scattered photons compared to in-air measured total
absorbed dose profile. Plot of the calculated absorbed dose versus off-axis distance, x, due to
head-scattered photons along with measured absorbed dose values. Measured total absorbed
doses correspond to in-plane and cross-plane profiles for a 5x5 cm2 field measured in air at an
SPD of 101.5 cm.
Table 3.4 lists all parameters involved in calculating dose due to head-scattered photons
in both air and water. These parameters were found following methods described in Section
2.1.14. The model parameters describing the absorbed dose due to head-scattered photons
developed in air were also used in the calculation of absorbed dose in a water-phantom with
Equation 2.52. Additionally, the empirical adjustment parameter to the water attenuation
coeffici ent for head-scattered radiation was included in the model for dose in water. Figure 3.6
shows the absorbed dose due to head-scattered photons in a water-phantom along with measured
total absorbed dose.
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Table 3.4 – Parameters for the absorbed dose from head-scattered photons.
Symbol
Description
9, Constant of proportionality for the
head-scatter Gaussian Pa@² ∙ @² 0I ∙
aa0$∙I/ Q
u
Exponent defining power law
relationship between the amplitude and
field area
s
Divergence factor for head-scattered
absorbed dose
9,G Constant of proportionality for the
head-scatter Gaussian width parameter
Paa ∙ aa0I/ Q
Adjustment parameter for the µt of
M
water for head-scattered absorbed dose
hrw'E Cut-off field area defined in the
isocentric plane (cm2)
SFFD Effective-source-to-flattening-filterdistance (cm)

In-Plane
4.66 × 10Å

Cross-Plane
4.15 × 10Æ

3.59

2.62

This
Work11

2.07

2.55

0.72
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Figure 3.6 – Absorbed dose due to head-scattered photons compared to total absorbed dose
profiles measured in water. Plot of calculated absorbed dose due to head-scattered radiation
and total absorbed dose profiles measured in both the in-plane and cross-plane directions.
Measurements represent a 5x5 cm2 field with the water-phantom at an SSD of 100 cm and the
chamber at a depth of 1.5 cm in water.
11
12

From iterative fitting procedure
(Elekta Digital Linear Accelerator User Manual, 2007)
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In Figure 3.5 it can be seen that the dose due to head-scattered photons represents nearly
all of the dose deposited in the near-field region in air. A very small contribution to the total
dose in this region also comes from leakage photons. Figure 3.6, however, shows that in water,
the absorbed dose from head-scattered photons represents a comparatively smaller, but still
significant portion of the total dose in this region. This is because in water the phantomscattered photons also deposit a large contribution to the total absorbed dose in this region.
Following the methodology outlined in Section 2.1.12, namely Equation 2.54, the
absorbed dose due to phantom-scattered photons was calculated. Figure 3.7 shows the calculated
absorbed dose from phantom-scattered photons along with water-tank measured total absorbed
dose values. It should be noted that the phantom-scatter dose is modeled the same in the in-plane
and cross-plane directions at each depth and thus only one calculated curve is shown in this
figure. Table 3.5 lists all parameters involved in calculating this portion of the dose. In Figure
3.7 it can be seen that the absorbed dose due to phantom-scattered photons significantly
contributes to the total dose in the near-field region; and it continues to deposit dose much
further from the CAX than the head-scattered photons.
3.1.5 Calculated Total Absorbed Dose in a Water-Phantom
The total absorbed dose in both air and water was calculated as described in Section
2.1.1, specifically using Equation 2.1. Figure 3.8 shows each of the calculated dose components,

 ,  ,  , and  , the calculated total absorbed dose,  , and the measured total absorbed
dose profile for a representative case. Figure 3.9 shows these same measured and calculated

total absorbed dose profiles along with the relative local dose deviations. In this plot, it can be
seen that the largest deviations between calculated and measured dose values exist in the areas of
steep dose gradients. This was expected because in these regions, small offsets between

52

measured and calculated dose profiles result in large relative local deviations. There also
appears to be a systematic underestimation of dose just outside of the treatment field, which will
be discussed in more detail later.

Figure 3.7 – Absorbed dose from phantom-scattered photons compared to a measured watertank absorbed dose profile. Plot of calculated phantom-scatter absorbed dose and measured
total absorbed dose values for both in-plane and cross-plane profiles. Total absorbed dose was
measured for a 5x5 cm2 field with an SSD of 100 cm and a measurement depth of 1.5 cm.
Table 3.6 lists the relative RMS deviation between calculated and measured total
absorbed dose for each training profile in water. In this table, it can be seen that all but one field,
the 5x5 cm2 field measured at a depth of 10 cm in the cross-plane direction, passed the criterion
stated in Specific Aim 1 (See Section 1.2) of 10% or better agreement in water. However, this is
because this profile was measured for this work while all others listed in this table were
measured by Kaderka et al. (2012). As previously mentioned, the measurements from this work
had a significantly lower dose resolution than those from Kaderka et al., which most seriously
affected dose measurements in the far-from-field region. This is also the region where small
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absolute dose differences correspond to large relative differences and thus, a very large relative
RMS error.
Table 3.5 – Parameters for the absorbed dose from the phantom-scattered photons. List of
parameters for the calculation of the phantom-scatter absorbed dose.
Symbol
Description
Constant of proportionality for the double9
w
b

9,G,I
f
9,G,$
h

C

M,I
M,$

13

Gaussian amplitude a@² ∙ @² 0I ∙ aa0$∙º∙Ç
Exponent defining power law relationship
between the amplitude and field area
Exponent defining power law relationship
between amplitude and depth
Constant of proportionality for the width
Â Â

d=1.5 cm d=10 cm Source
This
3.8 × 100$
Work13
1.7
1.9

parameter of Gaussian 1 aa ∙ aa 
ÉÂ
Ê

12

Exponent defining power law relationship
between width parameter of Gaussian 1 and field
size
Constant of proportionality for the width

parameter of Gaussian 2 aa ∙ aa
Exponent defining power law relationship
between width parameter of Gaussian 2 and field
area
Partitioning factor for the two Gaussians making
up the phantom-scatter double-Gaussian
Adjustment parameter to the µd of the phantomscattered photons in Gaussian 1
Adjustment parameter to the µd of the phantomscattered photons in Gaussian 2
ÉÂ
Ë

From iterative fitting procedure
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This
Work13
This
Work13
This
Work13

3.0

This
Work13

1.1

This
Work13

1.6

This
Work13

0.59

0.80
1.7
2.5

This
Work13
This
Work13
This
Work13

Figure 3.8 – Calculated absorbed dose components and total absorbed dose compared to a
measured total absorbed dose profile in water. Plot of each of the components of the calculated
total absorbed dose along with their sum and measured total absorbed dose. Doses were
measured in the cross-plane direction for a 10x10 cm2 field with an SSD of 100 cm and at a
depth of 1.5 cm in water. Error bars represent one standard deviation as given by Kaderka et
al..

Figure 3.9 – Calculated total absorbed dose compared to measured total absorbed dose with
relative local difference. Plot of the calculated total absorbed dose along with measured total
absorbed doses for a 10x10 cm2 field, SSD of 100 cm, and depth of 1.5 cm in a water-phantom
in the cross-plane direction. Also, indicated on the right ordinate, is the relative local dose
difference.
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Table 3.6 – RMS relative local deviations between measured and calculated total absorbed dose
in water.
Field Size
(cm²) SSD (cm)

Depth
(cm)

100

1.5

100

10

100

1.5

5x5

10x10

All Fields

Profile
In-plane
Cross-plane
In-plane
Cross-plane
In-plane
Cross-plane

RMS
7.57
5.79
8.22
35.81
9.29
7.97
30.14

3.2 Model Validation
A one-dimensional gamma index (see Section 2.2.1) was used to verify that 90% of
calculated dose values passed within 10% of measured dose values or 3 mm in the in-field region
of dose measurements and within 2 mGy/Gy or 10 mm in the out-of-field region for each
validation field profile. Table 3.7 lists the results of the gamma index analysis on validation
profiles measured in air, including the maximum and average γ values as calculated using
Equation 2.67 as well as the fraction of points receiving a passing γ value of less than or equal to
1. In this table it can be seen that only three of the validation profiles in air passed at 90% of
positions studied. The passing profiles represented the reference conditions as well as the inplane 20x20 cm2 field size. Deviations from the reference conditions in terms of source to
calculation plane distance and aspect ratio resulted in gamma index values greater than one for
more than 90% of locations studied in air.
Figure 3.10 shows γ index values versus off-axis position for the 10x10 cm2 field
measured in the cross-plane direction, in air, at an SPD of 110 cm. This field had a passing rate
of about 83%, approximately equal to the passing rate for all fields and thus was considered to be
a representative case. The solid black line separates the in-field region from the out-of-field
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Table 3.7 – Results of one-dimensional gamma index analysis on in-air validation data. List
of the maximum and average gamma index value for each validation profile measured in-air
with the gamma index criteria of 10% or 3 mm inside of the treatment field and 2 mGy/Gy or
1 cm outside of the treatment field. Also, the fraction of points passing with a gamma value
less than or equal to 1 for each profile is listed. The final row lists the maximum, average, and
fraction of all in-air measured doses passing the gamma index analysis criteria for all fields
studied.

region as determined by Equations 2.61 and 2.62 while the dashed line separates passing and
failing gamma index magnitudes. From this plot, it can be seen that while a larger number of
failing points were located inside of the treatment field, those that failed outside of the treatment
field on average had greater γ values, indicating that they were further outside of the agreement
criteria. It can also be seen in this plot that the failing γ values were systematically clustered
around the near-field region while the far-from-field region passed with gamma values well
below 1.
Table 3.8 lists the results of the gamma index analysis on validation profiles measured in
water. In this table it can be seen that all square-field validation profiles passed for at least 90%
of measured positions. Changes in depth, SSD, and field area with respect to the reference
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In-Field
Region

Out-of-Field
Region

Pass

Fail

Figure 3.10 – Gamma index versus off-axis position for a representative profile in-air. Plot of
the gamma index for each measured position for the 10x10 cm2 treatment field at an SPD of 110
cm in the cross-plane direction. The vertical line separates points that are defined to be in the
treatment field from those considered to be out-of-field based on the criteria described in
Section 2.2.1.
conditions of a 10x10 cm2 field measured at a depth of 1.5 cm in a water-phantom at an SSD of
100 cm were accurately modeled by the algorithm. Deviations from these reference conditions
in the aspect ratio generally yielded gamma index results that did not pass for at least 90% of
locations studied.
Figure 3.11 shows γ versus off-axis position, x, for the 20x20 cm2 field measured in the
in-plane direction, in a water-phantom at an SSD of 100 cm and with a measurement depth of 1.5
cm. This field had a passing rate of about 92%, approximately equal to the passing rate for all
data points and thus was considered to be a representative case. As in Figure 3.10, the solid
black line separates the in-field region from the out-of-field region, as determined by Equations
2.61 and 2.62, while the dashed line separates passing and failing gamma index magnitudes.
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Table 3.8 – Results of one-dimensional gamma analysis on water-phantom validation data.
Table presenting the maximum and average gamma index value for each validation profile
measured in water as well as the percentage of total values passing with a gamma value less
than or equal to 1. The last row lists the maximum, average, and percentage passing for all inwater measured doses.

While this plot did have passing gamma index results at greater than 90% of points, it can be
seen that those points that did fail were, on average, very far from the agreement criteria. Also,
as was the case with the previously discussed in-air profile, the failing points were clustered
around the field edge. It should be noted that this is also where the systematic underestimation
of dose was observed in Figure 3.9. Unlike the in-air profile in Figure 3.10, the majority of
locations inside of the treatment field passed with γ values far lower than 1. It should also be
noted that the sharp drop in gamma index magnitude at the location of the black solid line is
explained by the change in gamma index criteria at this point as was discussed in Section 2.2.1.
Figure 3.12 shows the fraction of the total absorbed dose represented by each dose

component,  ,  , and  , as a function of off-axis position. As in the previous two figures, the
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Out-of-Field
Region
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In-Field
Region

Pass

Fail

x (cm)
Figure 3.11 - Gamma index versus off-axis position for a representative profile in a waterphantom. Plot of the gamma index calculated for the in-plane measured profile of a 20x20 cm2
treatment field at an SSD of 100 cm and a measurement depth of 1.5 cm in a water-phantom.
The vertical line separates points that are defined to be in the treatment field from those
considered to be out-of-field based on the criteria described in Section 2.2.1.
in-field and out-of-field regions are separated by the solid vertical line. From this figure, it can
be seen that by far, the largest component of the total dose in the near-field region is from the
absorbed dose from scattered photons. This region being where more significant gamma index
failures were observed both in air and water-phantom indicates possible shortcomings in the
model for scattered dose, which will be explored further in Section 3.3.
3.3 Uncertainty analysis
A rigorous propagation of uncertainties was performed for the developed absorbed dose
model following the methods outlined in Section 2.3. This was done in order to independently
assess the accuracy of the model. Our analysis of uncertainty in the model of the un-collimated
primary photon fluence and the absorbed dose from the collimated fluence, leakage fluence,
head-scatter virtual source, and phantom-scatter virtual source in water are presented in Sections
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Figure 3.12 – Ratio of each dose component to the total absorbed dose versus off-axis position.
Plot of the ratio of each dose component to the total absorbed dose with respect to off axis
position for the reference conditions of a 10x10 cm2 treatment field measured at a depth of 1.5
cm in a water tank at an SSD of 100 cm, scanned in the in-plane direction. The solid vertical
line located at 6.5 cm separates the in-field region from the out-of-field region.
3.3.1 through 3.3.5. Finally, in Section 3.3.6, we estimated the uncertainty in the total absorbed
dose model.
3.3.1 Uncertainty in Un-Collimated Primary Photon Fluence
In this section we present the results of our estimation of the uncertainty in the uncollimated primary photon fluence model. Table 3.9 lists the relative uncertainty which was
estimated for each parameter involved in the model representation of the un-collimated primary
photon fluence (see Section 2.1.2).
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Table 3.9 – Uncertainty budget for the parameters for un-collimated primary photon fluence.
Symbol
B

B


BÌ"Å%&#
BE̅ Â
BE̅ F
BNO
BGO
BX

Description
Uncertainty in the average beam energy
Uncertainty in the mass energy absorption coefficient for
2 MeV photons
Uncertainty in the photon yield for 6 MeV electrons in
tungsten
Uncertainty in the mean of the central Gaussian
Uncertainty in the mean of the peripheral Gaussians
Uncertainty in the charge of electrons incident on the
target producing photons in each Gaussian
Uncertainty in the width parameter of each Gaussian
Uncertainty in the exponent driving the divergence of the
un-collimated photon fluence

Relative
Source
Uncertianty
10%
This
Work14
.01%
This
Work15
1%
This
Work16
5%
This
Work14
10%
This
Work14
10%
This
Work14
10%
This
Work14
5%
This
Work14

The uncertainties listed in Table 3.9 were propagated to find the uncertainty in the uncollimated primary photon fluence using Equation 2.68. In order to evaluate this uncertainty at
the four discrete locations described in Section 2.3: on the CAX, at the 5% off-axis-ratio
position, and at 15 cm and 30 cm off-axis, the uncertainty was calculated for the fluence
projected to an SPD of 101.5 cm. The absolute and relative uncertainties at each of these four
locations for both the in-plane and cross-plane directions are presented in Table 3.10. From this
table it can be seen that the relative uncertainty in the un-collimated primary photon fluence only
slightly decreases with off-axis position in both the in-plane and cross-plane direction. Also,
while the absolute uncertainty in the un-collimated photon fluence is slightly larger in the crossplane direction than the in-plane direction at all locations studied, the relative uncertainty is

14

Estimated
Estimated from (Hubbell & Seltzer, 2011)
16
Estimated from (Attix, 1986)
15
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lower. This can be explained by the wider profile of the un-collimated photon fluence in the
cross-plane direction as depicted in Figure 3.1.
Table 3.10 – Uncertainty in the un-collimated primary photon fluence. List of the uncertainty
in the un-collimated primary photon fluence projected to an SPD of 101.5 cm at four off-axis
representative locations: on the CAX, at the 5% off-axis ratio position, and at 15 cm and 30
cm from the CAX.
ÍÎ
In-Plane (%)
In-Plane (1/cm2)
Cross-Plane (%)
Cross-Plane (1/cm2)

CAX
10.8%
1.85 × 10Å
9.48%
1.95 × 10Å

5%
10.8%
1.84 × 10Å
9.48%
1.94 × 10Å

15 cm
10.7%
1.83 × 10Å
9.44%
1.93 × 10Å

30 cm
10.6%
1.77 × 10Å
9.30%
1.87 × 10Å

3.3.2 Uncertainty in Absorbed Dose from Collimated Primary Photon Fluence

Table 3.11 presents the relative uncertainties estimated for all parameters involved in the
model calculation of the absorbed dose in water due to the collimated photon fluence using
Equation 2.27. Note that the un-collimated photon fluence appears in this equation and thus,
Table 3.11 only includes those additional parameters not already given in Table 3.9.
The uncertainties listed in Table 3.10 and Table 3.11 were used to calculate the
uncertainty in the absorbed dose from the collimated photon fluence with Equation 2.70. This
uncertainty, evaluated at each of the four locations of interest in both the in-plane and crossplane directions, is presented in Table 3.12.
The first thing to note from this table is that the absolute uncertainty is 0 mGy/Gy at offaxis positions far outside of the treatment field. This is because the absorbed dose from the
collimated photon fluence is defined to be 0 mGy/Gy outside of the treatment field (See Section
2.1.3). Additionally, while the absolute uncertainty falls drastically between the central axis and
the 5% off-axis-ratio position, the relative uncertainty is roughly constant. Uncertainties are
comparable in the in-plane and cross-plane directions with slightly larger uncertainties found in
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Table 3.11 – Uncertainty budget for the parameters involved in calculating the absorbed dose in
water from the collimated photon fluence.
Symbol
BÐÑ

O

BÐÒÓF
BÐÔ
B

O

BÕÖ

BÐº
Bº
BÕ

B«

B««

Description
Uncertainty in the empirical adjustment parameter
for the incident electron charge producing photons in
each Gaussian
Uncertainty in the empirical adjustment parameter
for the mean of each peripheral Gaussian
Uncertainty in the empirical adjustment parameter
for the width parameter of central and peripheral
Gaussians
Uncertainty in the collimation factor (see Equation
2.24)
Uncertainty in the distance from the effective photon
source to the virtual photon source
Uncertainty in the empirical adjustment factor to the
µt of water
Uncertainty in the linear attenuation coefficient of
water for 2 MeV photons
Uncertainty in the depth in water
Uncertainty in the source-to-surface-distance
Uncertainty in the source-to-diaphragm-distance

Relative
Uncertainty
5%

5%
5%

5%
5%
5%
0.02%
5%
0.3%
In-Plane:
0.02%
Cross-Plane:
0.03%

Source
This
Work17
This
Work17
This
Work17
This
Work17
This
Work17
This
Work17
This
Work18
This
Work17
This
Work17
From
Literature19

Table 3.12 – Uncertainty in absorbed dose from the collimated primary photon fluence. List of
the uncertainty in absorbed dose from the collimated primary photon fluence evaluated at four
locations of interest: on the CAX, at the 5% off-axis ratio position, and 15 cm and 30 cm from
the CAX.
Í×Ø
In-Plane (%)
In-Plane (mGy/Gy)
Cross-Plane (%)
Cross-Plane (mGy/Gy)

CAX
13.9%
127
17.9%
164

5%
13.4%
1.15
17.2%
1.52

17

Estimated
Estimated from (Hubbell & Seltzer, 2011)
19
(Elekta Digital Linear Accelerator User Manual, 2007)
18
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15 cm
N/A
0.00
N/A
0.00

30 cm
N/A
0.00
N/A
0.00

the cross-plane direction. This is most likely due to the fact that empirical fit parameters were
generally larger in the cross-plane direction than the in-plane direction, resulting in larger
absolute uncertainties in these values for the same estimated relative uncertainty.
3.3.3 Uncertainty in Absorbed Dose from Leakage Photon Fluence
Table 3.13 lists the relative uncertainties estimated for all parameters involved in the
calculation of absorbed dose from leakage fluence using Equation 2.42. It should be noted that
again, the un-collimated photon fluence appears in Equation 2.42, for which the uncertainty was
presented in Section 3.3.1. Additionally, some parameters are shared between the models for

absorbed dose from collimated fluence and that from leakage fluence, namely 5 and Mº , for
which uncertainties were given in Table 3.11.

Table 3.13 – Relative uncertainty in parameters for the absorbed dose from leakage fluence.
Symbol
B

B¹¯

BÐ¹¯
B6¹¯

B·¯

BÐ·¯

B5·¯

Description

Relative
Source
Uncertainty
Uncertainty in the off-axis shape of the un-attenuated
5%
This
leakage fluence
Work20
Uncertainty in the linear attenuation coefficient of the
10%
This
secondary collimator
Work20
Uncertainty in the empirical adjustment factor to the linear
5%
This
attenuation coefficient of the secondary collimator
Work20
Uncertainty in the thickness of the secondary collimator
0.009%
This
Work21
Uncertainty in the linear attenuation coefficient of the
15%
This
primary collimator
Work20
Uncertainty in the empirical adjustment factor for the
5%
This
linear attenuation coefficient of the primary collimator
Work20
Uncertainty in the proximal width of the primary
20%
This
collimator
Work20

The uncertainty in absorbed dose from leakage fluence at each of the four locations of
interest was calculated using Equation 2.71. The results of these calculations are listed inTable

20
21

Estimated
Estimated from (Elekta Digital Linear Accelerator User Manual, 2007)
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3.14. In this table it can be seen that the absolute uncertainty in the absorbed dose from leakage
fluence is 0 mGy/Gy inside of the treatment field (on the CAX), where the leakage component of
the dose is zero by definition. It was found that in both planes, the absolute uncertainty is largest
near the field edges and decreases with increasing distance from the CAX. While uncertainties
were comparable in the in-plane and cross-plane directions, the cross-plane did have slightly
larger magnitudes at every position studied. This is most likely due to the fact that empirical
adjustment parameters were generally larger in the cross-plane than in-plane direction.
Table 3.14 – Uncertainty in the absorbed dose from leakage fluence. List of the absolute and
relative uncertainty in the absorbed dose from leakage fluence at four off-axis locations of
interest: on the CAX, at the 5% off-axis ratio location, and 15 cm and 30 cm from the CAX.
Í×Ù
In-Plane (%)

CAX

5%

15 cm

30 cm

N/A

0.0913%

0.0924%

0.0961%

In-Plane (mGy/Gy)

0.00

0.00178

0.00162

0.000654

Cross-Plane (%)

N/A

0.21%

0.209%

0.247%

Cross-Plane (mGy/Gy)

0.00

0.00402

0.00363

0.00219

3.3.4 Uncertainty in Absorbed Dose from the Virtual Source of Head-Scattered
Radiation
The estimated relative uncertainty in each parameter involved in the model calculation of
absorbed dose from the head-scatter virtual source using Equation 2.52 is presented in Table
3.15. These uncertainties were used with Equation 2.73 to calculate the uncertainty in the
absorbed dose from head-scattered photons. This uncertainty was evaluated at four off-axis
locations of interest for both the in-plane and cross-plane directions and are given in Table 3.16.
First, it should be noted that the absorbed dose from head-scattered photons was found to be
negligible far from the treatment field. Thus, relative uncertainty comparisons in this region (i.e.
at 15 cm and 30 cm from the CAX) were unrepresentative and have been excluded. In Table
3.16 it can be seen that the absolute uncertainty in the calculated head-scatter dose drastically
decreased with off-axis position. The relative uncertainty, on the other hand, showed a much
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weaker dependence on distance from the CAX in the region where it could be calculated. Also,
the absolute uncertainty in the cross-plane direction revealed a weaker position dependence than
that in the in-plane direction. This was expected because the Gaussian shape of the head-scatter
absorbed dose profile in the cross-plane direction was characterized by a larger width parameter
and thus maintains a larger magnitude further from the CAX than in the in-plane direction.
Table 3.15 – Uncertainty budget for parameters for the absorbed dose from the virtual source of
head-scattered radiation.
Symbol
BÚÀ¹,°

BE¹¯ "=#
B

B«
B

BÚÀ¹,Ô
B

BÐÀ¹

Description
Uncertainty in the constant of proportionality for the
Gaussian amplitude
Uncertainty in the position of the secondary collimator
projected to the isocentric plane
Uncertainty in the exponent governing the relationship
between amplitude and field area
Uncertainty in the source-to-flattening-filter-distance
Uncertainty in the divergence factor for head-scattered
dose
Uncertainty in the constant of proportionality for the
width parameter of the head-scatter Gaussian
Uncertainty in the exponent governing the relationship
between the width parameter and field size
Uncertainty in the adjustment parameter for the µt of
water for head-scattered radiation

Relative
Source
Uncertainty
10%
This
Work22
0.1%
This
Work23
10%
This
Work22
0.06%
This
Work23
10%
This
Work22
5%
This
Work22
10%
This
Work22
5%
This
Work22

Table 3.16 – Uncertainty in absorbed dose from the virtual source of head-scattered radiation.
List of the uncertainty in absorbed dose from the head-scatter virtual source evaluated at 4 offaxis locations of interest: on the CAX, at the 5% off-axis ratio position, and at 15 cm and 30 cm
from the CAX, in both the in-plane and cross-plane directions.
Í×ÛÜ
In-Plane (%)
In-Plane (mGy/Gy)
Cross-Plane (%)
Cross-Plane (mGy/Gy)

22
23

CAX
172%
82.5
187%
72.8

5%
145%
36.9
169%
43.6

Estimated
Estimated from (Elekta Digital Linear Accelerator User Manual, 2007)

67

15 cm
N/A
1.09
N/A
5.86

30 cm
N/A
1.57 × 100Ý
N/A
1.82 × 100$

3.3.5 Uncertainty in Absorbed Dose from Virtual Source of Phantom-Scattered
Radiation
Table 3.17 lists the relative uncertainty budgeted for each parameter involved in the
model calculation of absorbed dose due to the phantom-scatter virtual source as calculated using
Equation 2.54. The uncertainties listed in Table 3.17 were utilized in Equation 2.74 to calculate
the uncertainty in absorbed dose from phantom-scattered photons. This uncertainty was
evaluated at four representative off-axis locations of interest. Unlike the previously discussed
absorbed dose models, the model for absorbed dose from phantom-scattered photons is the same
in the in-plane and cross-plane directions. Instead, parameters were fit independently for
changes in depth. Thus, Table 3.18 presents the uncertainty in the phantom-scatter absorbed
dose, at each of the four off-axis locations of interest, and for depths of 1.5 cm and 10 cm in
water. From this table it can be seen that both the relative and absolute uncertainty decrease with
increasing distance from the CAX at both depths studied. However, the uncertainty in the
absorbed dose at a depth of 10 cm showed a stronger off-axis position dependence than that at a
depth of 1.5 cm. This is most likely because the only phantom-scatter parameter that was fit
independently at each depth was C, the partitioning factor between each Gaussian making up the
double-Gaussian. This parameter was significantly larger at a depth of 10 cm than 1.5 cm. This
means that at the deeper depth, the model was more heavily weighted in the narrow Gaussian,
resulting in a generally stronger off-axis dependence in the dose profile at a depth of 10 cm than
at 1.5 cm.
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Table 3.17 – Uncertainty budget for parameters involved in absorbed dose from the virtual
source of phantom-scattered radiation.
Symbol
BÚ·¹,°
B5
B

BÚ·¹,Ô,Â
B{

BÚ·¹,Ô,F
B
B

BÐ·¹,O

Description

Relative
Source
Uncertainty
Uncertainty in the constant of proportionality for the
10%
This
double-Gaussian amplitude
Work24
Uncertainty in the exponent governing the relationship
10%
This
between amplitude and field area
Work24
Uncertainty in the exponent describing the power law
10%
This
relationship between amplitude and depth
Work24
Uncertainty in the constant of proportionality for the width
5%
This
parameter of Gaussian 1
Work24
Uncertainty in the exponent governing relationship
10%
This
between the width parameter of Gaussian 1 and field size
Work24
Uncertainty in the constant of proportionality for the width
10%
This
parameter of Gaussian 2
Work24
Uncertainty in the exponent defining the relationship
10%
This
between the width parameter of Gaussian 2 and field area
Work24
Uncertainty in the partitioning factor between the two
10%
This
component Gaussians
Work24
Uncertainty in the adjustment parameter to the µx of
5%
This
phantom-scattered radiation in each Gaussian
Work24

Table 3.18 – Uncertainty in the absorbed dose from the virtual source of phantom-scattered
radiation. List of the uncertainty in absorbed dose from phantom-scattered photons evaluated at
four off-axis locations of interest. Note that presented values apply to both in-plane and crossplane calculations as the model is shared between the two planes.
Í×ØÜ
d = 1.5 cm (%)
d = 1.5 cm (mGy/Gy)
d = 10 cm (%)
d = 10 cm (mGy/Gy)

CAX
73.2%
25.0
86.9%
51.4

5%
59.0%
8.26
67.9%
13.6

15 cm
61.0%
1.95
60.4%
1.26

30 cm
38.9%
0.274
39.0%
0.178

3.3.6 Uncertainty in Calculated Total Absorbed Dose
The uncertainties from each dose component presented in Sections 3.3.1 through 3.3.5
were used with Equations 2.69 and 2.72 to determine the uncertainty in the calculated total
absorbed dose. Table 3.19 presents the uncertainty in the total absorbed dose evaluated at each
of the four representative locations of interest in the in-plane and cross-plane directions.

24

Estimated
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Differences in uncertainty magnitudes between depths of 1.5 cm and 10 cm were found to be
negligible and thus, only the uncertainty at a depth of 1.5 cm is presented. From this table, it can
be seen that while the absolute uncertainty generally decreases with off-axis position, the relative
uncertainty peaks at the 5% off-axis-ratio location. This is consistent with the findings of
Specific Aim 2 (See Section 3.2) in that the gamma index analysis revealed that failures in water
were largely clustered around this 5% isodose location. By far, the largest contributor to the
uncertainty in this region was the absorbed dose from head-scattered photons. It can be seen
from Tables 3.16 and 3.19 that the uncertainty in the total absorbed dose is roughly equal to that
in the head-scatter dose at both the 5% and 15 cm locations. It was shown in Figure 3.12 that the
absorbed dose deposited by scattered photons, of which head-scattered photons are a component,
is the largest contributor to the total absorbed dose in this region. Thus, the uncertainty in the
total absorbed dose is greatly dependent on the large uncertainties found in this portion of the
model. With the exception of the off-axis position of 15 cm, uncertainties were comparable
between in-plane and cross-plane directions. The most likely explanation for this difference is
the wider width parameter of the head-scatter absorbed dose model in the cross-plane direction.
This causes the large uncertainties in this portion of the model to remain important at further offaxis distances while the contribution in the in-plane direction is negligible at the 15 cm location.
Í×Þ
In-Plane (%)
In-Plane (mGy/Gy)
Cross-Plane (%)
Cross-Plane (mGy/Gy)

Table 3.19 – Uncertainty in the total absorbed dose.
CAX
15.4%
153
18.3%
181

5%
75.69%
37.8
88.7%
44.4

70

15 cm
40.8%
2.23
82.9%
6.18

30 cm
19.8%
0.274
17.3%
0.275

Chapter 4 Discussion
A physics-based model was designed to calculate the total absorbed dose deposited both
inside and outside of the treatment field for 6 MV photon conventional radiotherapy. The model
includes separate terms for absorbed dose from primary, leakage, and scattered photons and was
developed to reproduce measured total absorbed dose profiles in a water-box phantom from 6
MV conventional photon radiotherapy. The algorithm was then validated against independently
measured profiles in water representing a range of clinically relevant photon field sizes, aspect
ratios, off-axis positions, and depths in a water-phantom. The major finding of this study is that
validation of the model revealed it was able to predict doses meeting the criteria of passing
within 25% or 3 mm of measured doses inside the treatment field and 2 mGy/Gy or 10 mm of
measured doses outside of the treatment field at 90% of measured positions for all square fields
studied in water.
4.1 Impact
Current treatment planning systems do not include the capability to accurately predict the
absorbed dose beyond a few centimeters outside of the treatment field (Taylor & Kron, 2011).
This was highlighted by two recent studies (Howell R. M., Scarboro, Kry, & Yaldo, 2010;
Joosten, Matzinger, Jeanneret-Sozzi, Bochud, & Moeckli, 2013), and in this work (Section 1.2).
Previous to this work, relatively few dose reconstruction algorithms were available. Of those
that have been developed, some only attempted to model certain components of the stray dose
rather than the total absorbed dose (Benadjaoud, et al., 2012; Chofor, Harder, Willborn, &
Poppe, 2012), others were based on measurements from outdated linacs (Stovall, et al., 2006;
Francois, Beurtheret, & Dutreix, 1988), and many authors failed to publish even the most basic
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aspects of their proposed models (Stovall, et al., 2006; Van der Giessen, 1996; Diallo, et al.,
1996).
This work suggests that it is feasible to improve dosimetric accuracy in near-field and
out-of-field regions using a simple and computationally fast physics-based analytical algorithm.
The potential improvements of out-of-field dose calculations through the use of analytical
models is illustrated by Figures 4.1 and 4.2. In Figure 4.1 it can be seen that the treatment
planning system significantly underestimates absorbed dose outside a distance of approximately
15 cm from the CAX while the analytical model proposed in this work continues to predict
measured doses at greater accuracy out to a distance of 35 cm from the CAX. Figure 4.2 shows
the calculated and absorbed dose profiles for a range of different field sizes, depths in phantom,
and SSDs. In this figure, it can be seen that the model presented in this work accurately predicts
the measured dose values for all of these various field configurations in all regions of the profile.
Absorbed dose calculated using analytical models could prove useful in a number of
different applications. The accurate knowledge of absorbed dose deposited outside of the
treatment field is especially important for predicting radiation late effects such as second cancer
(Newhauser & Durante, 2011), fertility complications (Perez-Andujar, Newhauser, Taddei,
Mahajan, & Howell, in press), cardiac toxicity (Zhang, et al., 2011), and other endpoints. One
way in which this algorithm could be used is the model in its entirety could be applied to
epidemiological and radiation-safety type applications in order to reconstruct absorbed dose for
retrospective radiotherapy studies or from radiation accidents. Also, when treating patients with
implanted electronic devices, such as defibrillators and pacemakers, the dose to the device must
be carefully tracked and kept below 2 Gy for pacemakers and only 1 Gy for defibrillators
(Marbach, Sontag, Van Dyk, & Wolbarst, 1994) in order to avoid device malfunction. The
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Figure 4.1 – Comparison of measured, TPS calculated, and model calculated total absorbed
dose. Plot of the total absorbed dose measured in a water-box phantom with a diamond detector
for a 10x10 cm2 treatment field at a depth of 1.5 cm along with total dose profiles predicted for
the same configuration by both a commercial treatment planning system and the analytical
model proposed in this work.
model developed in this work could be used as a tool to estimate the expected dose to these
devices from radiotherapy treatments. Another possible application is that the out-of-field
portion of this model could be integrated into contemporary treatment planning systems in order
to improve their current out-of-field dose calculations. For this, the in-field portion of the model
would aid in normalization between TPS and model calculated doses. Thus, we conclude that,
with additional development, analytical modeling of the total absorbed dose is a viable method
of routinely predicting or retrospectively determining the dose delivered both inside and outside
of the treatment field during photon radiotherapy treatments.

73

1000000

Dose (Arbitrary Units)

100000

A Calculated

A Measured

B Calculated

B Measured

C Calculated

C Measured

D Measured

D Calculated

10000
1000
100
10
1
0.1
0

5

10

15

20
x (cm)

25

30

35

Figure 4.2 – Measured and calculated total absorbed dose for a range of field configurations.
Plot of the measured and calculated total absorbed dose for a variety of field configurations.
Dose magnitudes have been offset by factors of 10 for visual clarity. A) 5x5 cm2, d= 1.5 cm,
SSD= 100 cm, cross-plane, B) 5x5 cm2, d= 10 cm, SSD= 100 cm, in-plane, C) 10x10 cm2, d=
1.5 cm, SSD= 85 cm, cross-plane, D) 10x10 cm2, d=1.5 cm, SSD= 100, cross-plane.
4.2 Previous Literature
When compared to previous works, the dose algorithm from this study is unique in its
ability to calculate total dose both inside and outside of the treatment field. Specifically, this
study is the first to consider all major sources of photon fluence in a physics-based analytical
model. As a result, direct comparisons of the entire model could not be made with the literature.
However, specific aspects of the results could be compared with previous works, specifically
those of Kaderka et al. (2012), Zhang et al. (2011), Taddei et al. (in review), Chofor et al.
(2012), Benadjaourd et al. (2012), and Stovall et al. (1995).
Kaderka et al. (2012) performed out-of-field dose measurements in a water phantom for
four different treatment modalities, including 6 MV conventional photon beams. These
measurements were used to train the analytical model and thus, agreement between measured
profiles from Kaderka et al. and calculated absorbed doses from work were detailed in Section
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3.1. One of the profiles published in their work, the 10x10 cm2 treatment field measured at a
depth of 1.5 cm in a water-phantom at an SSD of 100 cm, was repeated for the validation portion
of this work. Absorbed dose values measured for this work were found to be in good agreement
with those published by Kaderka et al. as evidenced by an average relative local dose difference
of 1.5% inside of the treatment field and 0.4 mGy/Gy in the out-of-field region.
To our knowledge, the first study to attempt to analytically model the total out-of-field
absorbed dose was reported by Zhang et al. (2011). In this work, total absorbed dose was
measured with TLDs in an anthropomorphic phantom and was fit with a double-Gaussian to a
distance of 19 cm from the field edge. The in-field portion of the beam was excluded from the
model. Following these methods, Taddei et al. (in review) developed and tested an analytical
model consisting of two gaussians to predict out-of-field dose during craniospinal irradiation
using 6 MV photons from two different linacs. Again, the total absorbed dose was measured
with TLDs in an anthropomorphic phantom. Unlike this work, in which the double-Gaussian
term represents only the dose deposited by phantom-scattered photons, the double-Gaussian in
Zhang et al. and Taddei et al. was used to calculate the total out-of-field absorbed dose. Due to
this key difference, direct comparison of model parameters is not possible. However, the general
finding of both Zhang et al. and Taddei et al., that the out-of-field absorbed dose could be
accurately modeled by a simple analytic model consisting of a combination of Gaussians, is in
good agreement with this work. In this work, the major components of out-of-field dose,
especially in the near-field region, were modeled as a combination of Gaussians, two for the
phantom-scatter absorbed dose and one for the head-scatter absorbed dose.
In their work, Chofor et al. (2012) considered the dose due to internal scatter, referred to
here as “phantom-scatter”. In particular, Chofor et al. used Monte Carlo methods to develop an
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empirical model to calculate the internal scatter component of dose using a double exponential
function however, the manuscript neglected to report the level of agreement between calculated
and simulated dose values. Comparison of the model proposed by Chofor et al. to the model for
absorbed dose from the phantom-scatter virtual source in this work, both calculated for a 5x5
cm2 treatment field in water, revealed an average dose difference of only 0.15 mGy/Gy.
Qualitatively, both models used simple analytical formulas to predict the internal scatter
component. However, our results suggest that the double-Gaussian function approach is
physically more realistic than the double-exponential due to the discontinuity that arises on the
central axis. In this same publication, Chofor et al. also studied the energy spectrum of the
internally scattered photons. They did not, however, report energy spectra closer to the treatment
field than 19.5 cm. Qualitatively they found that the average energy decreased with increasing
distance from the treatment field, eventually reaching a value of approximately 500 keV at 25.5
cm from the beam central axis. Our estimates of the linear attenuation coefficient of water for
the phantom-scattered photons in the wider Gaussian correspond to an average energy of
approximately 400 keV and are therefore in good agreement with this study. Finally, Chofor et
al. estimated a combined head-scatter and leakage magnitude of 0.3% for a 5x5 cm2 field, which
they assumed was independent of distance from the treatment field. The average combined
magnitude of calculated absorbed dose from head-scatter and leakage radiation for a 5x5 cm2
field from this work was 0.5%, which is in good agreement with the findings of Chofor et al..
Benadjaoud et al. (2012) also developed a semi-empirical model for the head-scattered
and leakage components of the stray dose. More specifically, they used dose measurements from
three different treatment machines to design a multi-plane source model for the head-scatter
dose. They reported a median difference in normalized local dose between measurements and
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calculations of 9%. The basis of their model matched that of ours, that the total stray dose was
equal to the sum of that due to leakage, head-scatter, and phantom-scatter dose. However, unlike
this study, Benadjaoud et al. did not address the dose due to primary photon fluence, nor did they
attempt to model the phantom-scatter portion of the dose. Also, their model for the headscattered radiation included multi-plane sources located on the edges of the collimation system
where as our head-scatter virtual source was located in the flattening filter. Additionally, the
model presented by this work was simpler than that of Benadjaoud et al.. Due to the complexity
of their model, we could not reproduce their results and therefore, a direct comparison of
calculated doses was not possible. Both models do, however, include a field size dependence of
the head-scatter dose as well as an average photon energy of 2 MeV for a 6 MV photon beam.
Benadjaoud et al. additionally estimated the magnitude of the leakage dose for 6 MV photon
fields at a depth of 10 cm in a water tank, regardless of field size, to a distance of 70 cm from the
beam central axis. They reported that the leakage absorbed dose decreased with distance from
the field edge and had a magnitude ranging from 0.005% to 0.13%. The corresponding leakage
absorbed dose calculated from the model presented in this work ranged from 0.01% to 0.13%. A
possible reason for the higher calculated absorbed dose from leakage photons in this work is that
the model was only trained and validated to a distance of 40 cm from the CAX while the
estimate by Benadjaoud et al. extended significantly further from the CAX.
In 1995, the American Association of Physicists in Medicine (AAPM) published Task
Group 36 on techniques to estimate and reduce fetal dose from radiotherapy (Stovall, et al.,
1995). This report included an appendix presenting out-of-field dose measurements for a range
of photon beam energies and depths in the phantom. Measurements were performed in either
water or polystyrene using TLD or diode detectors. 6 MV photon beam measurements were
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performed on a contemporary linac at the time (Varian Clinac 2100C, Varian Medical Systems,
Palo Alto, CA). Figure 4.3 shows this data along with measured and calculated dose values for
the same field size from this work. Error bars shown for this work represent one standard
deviation conservatively estimated with a 5% relative dose error and .3 mGy/Gy absolute dose
uncertainty based on the quantization error. Error bars for Stovall et al. (1995) represent one
standard deviation estimated based on previously published uncertainty in out-of-field TLD
measurements for a 6 MV photon beam (Kry, Price, Followill, Mourtada, & Salehpour, 2007).
From this figure it can be seen that the profiles are all in reasonably good agreement with even
far-from-field measurements well within uncertainty values. Measurements from Stovall et al.
outside of 7 cm from the CAX were consistently larger than observed in this work. This is most
likely explained by differences in linac head shielding and collimator design between
contemporary machines in 1995 and today.
4.3 Study Strengths
This project had several notable strengths. First, it is the first to report a complete,
physics-based analytical model to calculate the total dose both inside and outside of the treatment
field from photon therapy treatments. To our knowledge it is the only such model that predicts
doses due to primary, leakage, and scattered photon fluences for clinically relevant field sizes
and depths in the phantom, out to a distance of 40 cm from the CAX. Furthermore, a potentially
important advantage of a physics-based approach to modeling absorbed dose, such as the
algorithm proposed in this work, is that the model is inherently more readily adaptable to a wide
variety of treatment units and treatment techniques than models based on empirical formulae or
machine specific lookup-tables, as has been previously available.
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Figure 4.3 – Comparison of this work to Stovall et al. (1995) measurements. All doses
measured for a 10x10 cm2 field of 6 MV photons at a depth of 10 cm in water and normalized
to 1000 mGy/Gy at a depth of dmax on the central axis.
Additionally, this model was trained and validated using absorbed dose measurements for
contemporary radiotherapy treatment units. The majority of previously available models of outof-field total absorbed dose were developed for equipment that is outdated and the validity of the
application of such models to modern linacs is unclear. This work also presented a rigorous
uncertainty analysis of the physics-based model, including propagation of errors. Finally, the
major strength of this work is that it demonstrated the possibility of the accurate and quick
calculation of the dose deposited from 6 MV, conventional photon therapy treatments for both
use in epidemiological type studies as well as integration into current treatment planning
systems.
4.4 Study Limitations
One limitation of our study is that the in-air training and all validation data was measured
using a farmer-type ion chamber. The large volume of this chamber leads to dose averaging in
regions of steep dose gradient. This affects the locations of the mean and magnitude of the width
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parameter for the Gaussian functions used to model the un-collimated source of photon fluence.
This was not a serious limitation because of the inclusion of empirical adjustment parameters
determined from small-volume chamber measurements.
A second limitation was that individual dose components were modeled and optimized
independently using only total dose measurements. This made it difficult to differentiate
between the different components of the total absorbed dose, specifically in the near field region
where multiple sources of stray dose are important. While this limitation introduced uncertainty
in each independently calculated component of dose, the summation of all components
reasonably predicts total absorbed dose in water and thus, the accuracy of this partitioning did
not significantly hinder the accuracy of the total absorbed dose model. Furthermore, the use of
both in-air and water-tank measurements aided in minimizing these issues.
Another minor limitation is that we estimated the average beam energy to be 1/3 of the
peak photon energy based on an assumed triangular photon spectrum. However, it is known that
the effects of filtration and beam hardening serve to preferentially remove low energy photons
from the beam and thus increase the average beam energy. While this was the best estimate
available within the scope of this project, it can be easily overcome with Monte Carlo
simulations or measurements.
Validation of the developed model in air revealed that it slightly underestimated absorbed
dose far from the treatment field with underestimations increasing in magnitude with field size.
However, this underestimation of out-of-field dose was not observed in the validation of the
model to water-tank measurements. The only difference between the model in air and water is
the additional absorbed dose from phantom-scattered photons. This suggests that some portion
of dose that is currently being calculated as phantom-scatter dose, which is only present in water,
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is actually due to head-scatter, which is present in both air and water measurements. This
indicates the need for further refinement of the head-scatter portion of the model.
Additionally none of the fields studied with aspect ratios other than 1:1 passed the
validation criteria. This revealed shortcomings of the model as developed with measured square
field data when applied to rectangular fields. However, we believe this limitation may be
overcome in a relatively straightforward manner with the inclusion of an additional aspect ratio
term in the scatter dose portion of the model.
Finally, the model, as developed, is not expected to apply to IMRT, which is a widely
used treatment modality today. However, we believe only minor adjustments would be
necessary to include this capability in the current analytical model.
4.5 Future Work
The encouraging results from this study indicate that it may be possible to calculate the
total absorbed dose for a variety of field sizes and shapes. However, it appears that the model for
absorbed dose from head-scattered photons requires the most immediate attention. A logical
next step would be to develop a more detailed characterization of the basic physics relating the
head-scatter dose to field size and shape in a simple phantom.
Beyond that, extensions to the model are needed for application to intensity modulated
radiotherapy (i.e. IMRT and arc therapies). We believe that similar methods to those used in
shielding calculations (NCRP, 2005) could be utilized to this end.
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Chapter 5 Conclusions
This work demonstrated that it is possible to calculate the absorbed dose, both inside and
outside of a conventional radiotherapy treatment field of 6 MV photons using a physics-based
analytical model. This work provided specific results which indicate the use of models, such as
the one developed in this project, can predict dose values with better accuracy in the out-of-field
region than current treatment planning system methods. This is demonstrated by the agreement
between measured and calculated doses within 10% or 3 mm inside of the treatment field and 2
mGy/Gy or 10 mm outside of the treatment field at 90% of positions for all square fields studied
in water. Additionally, the average magnitude of local relative deviations between measured and
calculated dose values for all in-water validation data was 14%, significantly better than that
achievable with contemporary commercial treatment planning systems.
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